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ABSTRACT OF DISSERTATION 
 
 
 
THE DYNAMIC NATURE OF CHROMATIN 
 
Eukaryotic organisms contain their entire genome in the nucleus of their cells. In order to 
fit within the nucleus, genomic DNA wraps into nucleosomes, the basic, repeating unit of 
chromatin. Nucleosomes wrap around each other to form higher order chromatin 
structures. Here we study many factors that affect, or are effected by, chromatin 
structure including: (1) how low-dose inorganic arsenic (iAs) changes chromatin 
structures and their relation to global transcription and splicing patterns, and (2) how 
chromatin architectural proteins (CAPs) bind to and change nucleosome dynamics and 
DNA target site accessibility.  
 
Despite iAs’ non-mutagenic nature, chronic exposure to low doses of iAs is associated 
with a higher risk of skin, lung, and bladder cancers. We sought to identify the genome-
wide changes to chromatin structure and splicing profiles behind the cell’s adaptive 
response to iAs and its removal. Furthermore, we extended our investigation into cells 
that had the iAs insult removed. Our results show that the iAs-induced epithelial to 
mesenchymal transition and changes to the transcriptome are coupled with changes to 
the higher order chromatin structure and CAP binding patterns. We hypothesize that 
CAPs, which bind the entry/exit and linker DNA of nucleosomes, regulate DNA target 
site accessibility by altering of the rate of spontaneous dissociation of DNA from 
nucleosome.  
 
Therefore, we investigated the effects of the repressive CAP histone H1, the activating 
CAP high mobility group D1 (HMGD1), and the neural CAP methyl CpG binding protein 
2 (MeCP2) on the dynamics of short chromatin arrays and mononucleosomes and their 
effect on nucleosomal DNA accessibility. Using biochemical and biophysical analyses 
we show that all CAP-chromatin structures tested were susceptible to chromatin 
remodeling by ISWI and created more stable higher order structures than if CAPs were 
absent. Additionally, histone H1 and MeCP2 hinder model transcription factor Gal4 1-
147 from binding its cognate DNA site within nucleosomal DNA.  
 
Overall, we show that chromatin structure is dynamic and changes in response to 
environmental signals and that CAPs change nucleosome dynamics that help to regulate 
chromatin structures and impact transcriptional profiles. 
 
 
 
KEYWORDS: Genome Compaction, Nucleosome Dynamics, Chromatin Dynamics,  
           Chromatin Architectural Proteins, Inorganic Arsenic, and Methyl CpG    
           Binding Protein 2  
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Chapter 1: Background and Introduction 
 
Genomic Compaction 
Chromatin, a DNA/protein complex, is responsible for compacting eukaryotic 
genomes in an orderly fashion so the genome fits within the nucleus. Nucleosomes are 
the most basic, repeating unit of chromatin and are formed when 147 base pairs (bp) of 
DNA wrap around a histone octamer core. In order to facilitate the compaction 
necessary to fit within the nucleus 75-90% of the genome is actively wrapped into 
nucleosomes1. The nucleosomes wrap around themselves in various conformations to 
create the ‘30 nm’ higher order chromatin structure. These 30 nm chromatin structures 
are difficult to detect in vivo and are subject to debate on how they form2,3. The 30 nm 
structure then wraps around itself condensing itself further, and this process of increased 
compaction through wrapping is repeated until the genome can fit within the nucleus, 
with the highest level of compaction observed during metaphase4.  
Chromatin is divided into two general classifications: heterochromatin and 
euchromatin. Heterochromatin is the highly condensed ‘inactive’ chromatin, while 
euchromatin is more relaxed and is found in the active regions of the genome. These 
differences in compaction are partially due to the nucleosome repeat length (NRL), the 
distance between two neighboring nucleosomes on a DNA strand. Just 1 additional bp to 
the NRL dramatically increases the nucleosome’s rotational freedom5, therefore, a 
region’s NRL is critical in determining its higher order structure. Heterochromatin 
requires longer and more consistent NRLs (the average NRL for heterochromatin is 205 
bp)6, to achieve its tight compaction. Euchromatin, however, with its more relaxed 
structure can have a dramatically lower and more varied NRL (average NRL of 
euchromatin is 178 bp)6.  
 
Nucleosome Structure and Dynamics 
 Every aspect of the nucleosome structure, not just their spacing, is critical in the 
genome’s compaction. Since most genomic DNA is wrapped around the histone core 
octamer, nucleosome stability must rely on non-sequence-specific interactions, which is 
achieved due to the opposing charges of the DNA and histone protein components. The 
histone octamer is made of two copies of each: H2A , H2B, H3, and H47. These four 
proteins have a similar structure with a globular domain, which is what comes together to 
form the ‘spool’ the DNA wraps around, along with a long N-terminal unstructured tail7. 
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Both regions of the histone proteins have many lysine (K) residues that contain a formal 
positive charge. DNA’s sugar-phosphate backbone has a formal negative charge per bp 
on each strand. Accounting for the double stranded nature of genomic DNA, wrapping 
147 bp around a histone octamer core neutralizes 15% of the DNA’s negative charges8. 
The remaining lysine residues on the histone tails can, if they are not post-translationally 
modified, fold back onto the nucleosome core to further neutralize some of the remaining 
negative charges. 
 While this charge based interaction allows for genome wide nucleosome 
formation it also results in a dynamic structure. ‘Nucleosome breathing’ is the 
spontaneous dissociation and reassociation of the DNA, particularly the DNA at the 
entry/exit region, from the histone octamer9-11. Due to the highly-charged nature of both 
components, the nucleosome is more stable in its ‘closed’ conformation10,12. In fact, 
nucleosomes with unmodified histones are found in their ‘open’ conformation, when the 
entry/exit DNA is dissociated from the octamer, only 4–6% of the time12. 
 With the majority of the genome wrapped into nucleosomes, transcription start 
sites (TSSs), replication origins, and other important DNA target sites will be wrapped 
into the nucleosome, resulting in their occlusion from their binding proteins. Thus, the 
dynamic nature of nucleosomes gives an opportunity for these cognate sites to become 
transiently available for binding. Therefore, any factor that affects the dynamic capability 
of nucleosomes (e.g. NaCl concentration, binding partners, histone post translational 
modifications [PTMs], and the rigidity of the particular higher order structures) will 
change the underlying accessibility of the DNA throughout the genome. Furthermore, 
changing the underlying DNA accessibility has the potential to affect every DNA 
templated event (e.g. transcription, replication, and repair). 
 
Chromatin Organization and Epigenetics in Gene Regulation 
Every cell within multicellular eukaryotic organisms contains the entire genome 
wrapped into chromatin. Therefore, regulatory mechanisms must be present to ensure 
cell/tissue specificity in the transcriptional profile. Accordingly, the proper chromatin 
structures genome wide are key for a cell’s transcriptional integrity. Since the chromatin 
structure is so critical for proper cell function and the DNA sequence is consistent 
throughout cells, the changes in chromatin organization are facilitated by the NRL, DNA 
methylation, histone PTMs, and chromatin remodelers. 
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Nucleosome Repeat Length: Changing the NRL, in addition to changing the 
higher order structure of regions of the genome, results in different cis target sites being 
exposed in the readily accessible linker regions of chromatin. Thus, unique NRLs 
between cells give rise to vastly different transcriptional repertoires. Within the brain 
alone, neurons have unique NRLs depending on development stage and brain region. 
Neurons of the cortex have a NRL of 200 bp during neurogenesis and, upon maturation, 
the NRL changes to 170 bp13. The neurons within the cerebellum, however, have a NRL 
of 165 bp during neurogenesis and 218 bp upon maturation13. Both of these NRL profiles 
differ dramatically from the liver, which has a consistent NRL of 200 bp throughout all 
stages of development13. Thus, while NRL is critical in determining the higher order 
structure chromatin can take, it is also critical for maintaining a cell’s transcriptional 
profile. 
Histone Post Translational Modifications: The lysine residues that occur 
throughout the histone octamer, in addition to providing the positive charge necessary 
for the nucleosome’s stability, are subject to covalent post translational modifications 
PTMs, as are the tyrosine, arginine, and serine residues 14,15. These PTMs include 
methylation, acetylation, SUMOylation, PARylation, and ubiquitylation16. The sum of 
these PTMs is known as the ‘histone code’, and is, perhaps, the most appreciated form 
of epigenetic regulation14,15,17,18. While there are some general guidelines for predicting 
how these modifications change the chromatin structure (e.g. acetylation leads to more 
open and relaxed chromatin) the effect of most modification patterns need to be 
determined experimentally. For example trimethylation of lysine 4 on H3 (H3K4me3) is 
found in activated regions of the genome, but if the trimethylation is just five amino acids 
away on lysine 9 (H3K9me3) it is associated with transcriptional repression16. 
Furthermore, dimethylation of this lysine (H3K9me2) is found in regions of the genome 
with gene activation16. Histone PTMs lead to either activation or repression by altering 
the underlying dynamics of the chromatin structures and/or by recruiting other 
complexes that alter these higher order structures. H3K4me3 weakens the interaction 
between the DNA and histone core octamer, thus resulting in a more dynamic 
nucleosome structure19, while acetylation of lysine 119 on histone H3 (H3K119ac) 
results in a more stable nucleosome structure19. Moreover, the H3K9/H3K36me 
combination interacts with the NCOR/SIN 3A co-repressive complex to maintain a 
repressed chromatin structure20, and the CREB co-activating complex interacts with 
H4K9ac/H3K14ac to maintain active chromatin regions16. Thus, by changing the 
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underlying dynamics and recruiting specific complexes, histone PTMs are multifaceted 
regulators of transcription. 
DNA Methylation: DNA is also susceptible to epigenetic modifications. DNA 
methylation, the addition of a methyl group on the carbon-5 of the cytosine base within a 
CG dinucleotide (CpG), is the most common modification to DNA in mammals21,22. 
Throughout the genome CpGs are underrepresented and, when found, are clustered 
together in “CpG islands” near gene promoters22. These methylated cytosines grouped 
in the CpG islands can block transcription factors from binding their TSSs23. 
Furthermore, DNA methylation recruits proteins with an affinity for methylated DNA to 
the CpGs24-26. These methyl-binding proteins (MBPs) are usually found within co-
repressive complexes27,28, thereby adding another level of transcriptional repression. 
Therefore, DNA methylation has traditionally been viewed as transcriptionally repressive. 
Recently, however, multiple discoveries have challenged this dogma. DNA methylation 
within gene bodies is associated with transcriptional activation29,30. This is potentially due 
to the decreased ability of the sporadically methylated DNA to wrap into chromatin31-33. 
Further challenging this dogma are the ten-eleven translocation (TET) enzymes, which 
oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC)34. The importance 
of 5hmC in transcriptional regulation is just starting to be examined, but there have been 
reports that in the brain 5hmC is just as prevalent as 5mC35. Furthermore, these studies 
suggest that 5hmC and 5mC are antagonistic regulators of transcription35. Thus, the 
emerging view of regulation due to DNA methylation emphasizes where and what type 
of methylation occurs. 
 Chromatin Remodelers: Like histone PTMs, ATP-dependent chromatin 
remodelers are a well-appreciated class of epigenetic regulators. ATP-dependent 
remodelers are found as complexes that can be made of up to eight separate proteins, 
but at a minimum have 1) an ATPase, 2) bind chromatin, and 3) change some aspect of 
the chromatin14. These complexes are divided into two general classes based on if they 
change the PTMs on the histone octamers15,36 or change the location of nucleosomes14. 
Both classes of remodelers have multiple modes of chromatin binding, which allows 
them to distinguish between a variety of epigenetic environments and directs the 
remodeling complexes to specifically target distinct epigenetic environments14. The first 
class of remodelers contain enzymes that can add or remove specific modifications such 
as acetyl, methyl, ubiquitin, SUMO, and phosphate groups14. Within this class histone 
acetyl transferases (HATs) and histone deacetyl transferases (HDACs) are the best 
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understood with regards to their downstream effect on chromatin structure. HAT 
complexes add acetyl groups and lead to a more relaxed structure15, while HDACs 
remove these acetyl groups and lead to more compacted chromatin organization36. The 
second class of ATP-dependent remodelers changes nucleosome location/occupancy 
by sliding, ejecting, or adding nucleosomes to a region of chromatin37. In addition to 
working with the already discussed epigenetic features, ATP-dependent remodeling 
complexes work with chromatin architectural proteins (CAPs) in order to provide specific 
and targeted chromatin remodeling38-40. 
 
Chromatin Architectural Proteins 
CAPs bind the entry and/or exit DNA of nucleosomes and are critical for the 
creation/maintenance of higher order chromatin structures. In vitro, model chromatin 
arrays without CAPs are unable to form the organized 30 nm structure under any salt 
condition3. A non-uniform organization of nucleosomes through a chromatin structure 
would be devastating, as heterochromatin requires consistent nucleosome spacing and 
wrapping6. Euchromatin, while more forgiving of its underlying nucleosome organization, 
still requires more organization than what non-CAP bound chromatin can provide6. As a 
class of protein, CAPs, like histone octamers, must be able to bind the entire genome. 
Therefore, CAPs also rely on a general charge based interaction with the nucleosomal 
DNA. However, as the model CAPs used in our studies (linker histone H1, methyl CpG 
binding protein 2 [MeCP2], high mobility group d 1 [HMGD1]) show, the structure and 
mode of interaction of CAPs and DNA can vary. Linker histone H1, which is not part of 
the histone core octamer, is composed of a 3 part structure: a disordered N-terminus, a 
globular domain (responsible for nucleosome binding), and a disordered C-terminus41. 
The neural CAP MeCP2 is over 60% disordered and contains only two domains with 
known secondary structure, the methyl binding domain (MBD) (responsible for 
nucleosome binding) and the transcriptional repression domain (TRD)42. Finally, HMGD1 
contains the HMG box, which is composed of three -helices in an ‘L’ orientation43. 
While all three model CAPs have a different form of nucleosomal DNA recognition: a 
globular domain, MBD, or HMG box, it is interesting to note that all three prefer to bind 
DNA in a parallel orientation, which is how DNA is oriented in nucleosomes41,44. 
Furthermore, most CAPs have limited secondary structure when unbound41-43,45. This 
allows them the flexibility to interact with multiple targets, including various epigenetic 
marks46-50. 
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While their mode of interaction can be different, CAPs bind the same location of 
the nucleosome and therefore compete with each other for binding24. CAPs bind 
different regions of the genome with different affinities24, which is critical for cellular 
function as CAPs help create/maintain higher order structures that have distinct 
transcriptional profiles. Thus, CAPs interact with epigenetic marks to direct their location 
throughout the genome. For example, acetylation of lysine 16 on H4 (H4K16ac) 
preferentially binds HMGD151, and MeCP2 preferentially binds regions of the genome 
with methylated DNA. Furthermore, CAPs themselves can by post translationally 
modified, which affect their function52,53 and their ability to bind other complexes (CREB, 
NCOR/SIN 3A, etc.)53  that alter chromatin structure. Thus, by interacting with numerous 
epigenetic marks CAPs can integrate many signals to provide nuanced transcriptional 
regulation. 
 
MeCP2 in Rett Syndrome 
 The importance of CAPs in maintaining the transcriptional integrity of cells is 
highlighted in the neurodevelopment disorder Rett Syndrome (RTT). Over 90% of RTT 
cases are due to de novo loss-of-function mutations of MeCP254. MeCP2 is expressed at 
low levels throughout neurogenesis and, upon maturation, levels dramatically increase 
to the point that there is 1 MeCP2: 2 nucleosomes. This is a level equal to the amount of 
histone H1 in mature neurons26. Interestingly, patients with RTT appear to develop 
normally for 6-18 months55,56, and RTT mice models also have this delayed symptom 
onset57,58, which is temporally linked with MeCP2’s expression level increase59. RTT has 
a wide variety of symptoms, both in severity and type, which include sleep disturbances, 
breathing abnormalities, and blindness 55,56. The signature RTT symptoms, in addition to 
the delayed onset, are lack of speech and hand wringing stereotypies55,56. 
 The only domains of MeCP2 with known secondary structures are the MBD and 
the TRD42. Together these domains lead to belief that MeCP2 is a transcriptional 
repressor, which was experimentally confirmed both in vivo60-63 and in vitro64,65. In fact, 
MeCP2 provides better repression of long genes66 and long non-tandem repeats26 than 
histone H1, the hallmark repressive CAP67-70. However, MeCP2 was also found to 
interact with the CREB co-activating complex to facilitate transcriptional activation of 
over 85% of the genes with which MeCP2 is associated71. Since this discovery, it has 
become clear that MeCP2 acts as both a repressive CAP and an activating CAP in 
neurons. However, the molecular mechanisms behind its function have remained 
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obscure. RTT-causing mutations can provide clues to this mechanism. RTT mutations 
occur throughout the entire protein, however the hot spot for disease-causing mutations 
are in the MBD and the TRD. The MBD is responsible for binding nucleosomes and/or 
gives MeCP2 a higher affinity for methylated DNA. The TRD is necessary for MeCP2 to 
repress transcription on the nucleosomes it binds. Mutations occurring outside of these 
domains also show how varied MeCP2 function is. A serine to alanine mutation at 
residue 80 (S80A) disrupts a phosphorylation site critical for regulating MeCP2’s 
interaction with chromatin72, while phosphorylation of the threonine at residue 308 
(T308) prevents the interaction of MeCP2 and the NCOR/SMRT co-repressive 
complex27,28. These mutations show the many different functions MeCP2 has in mature 
neuron transcriptional regulation and why its molecular mechanisms have remained 
elusive. 
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Chapter 2: Materials and Methods 
 
Micrococcal Nuclease Digestion 
Micrococcal nuclease (MNase) preferentially digests DNA not wrapped into 
nucleosomes. Thus, changes in nucleosome spacing can be determined by digesting 
bulk chromatin with MNase to produce a ‘nucleosome ladder’. This nucleosome ladder is 
the result of chromatin fragments containing mono-, di-, tri-, etc. nucleosomes. 
Therefore, the amount of MNase must digest enough bulk chromatin to produce a 
nucleosome ladder without over digesting so that only mono-, or very short nucleosome 
arrays remain. For this reason, all aspects of the MNase digestion, the number of nuclei, 
units (U) of MNase, and digestion time must be determined experimentally. The MNase 
digestions can be easily terminated with the addition of a chelating agent since it needs 
MgCl2 as a cofactor.  
 
Nucleosome Repeat Length Determination  
Using the guidelines described above, nuclei from BEAS-2B and HeLa cells ± iAs 
treatment were digested with MNase in 1 x MNase Reaction Buffer to generate 
nucleosome ladders. The digestions were stopped with the addition of MNase Stop Mix 
to a final 2 mM EDTA at room temperature (RT). The nucleosomal DNA was then 
isolated by digestion with 20 g Proteinase K for 1 hour at 37C followed by an ethanol 
precipitation (described below). The resulting DNA was analyzed on a 3.3% NuSieveTM 
agarose gel in 1 x TAE, stained with Ethidium Bromide (EtBr) and imaged on a Gel 
Doc™ by Bio-Rad. DNA ladders from NEB (50 bp, 100 bp, 1 kb) were used to generate 
a standard curve. Using the regression line generated by the DNA ladders and the 
distance between the nucleosomal bands the nucleosome repeat length (NRL) was 
calculated.  
Buffers:  
1 x MNase Reaction Buffer: 50 mM Tris-HCl pH 8.0, 1 mM CaCl2, 15 mM NaCl  
MNase Stop Mix: 10 mM EDTA pH 8.0, 1% SDS 
1 x TAE: 40 mM Tris, 20 mM acetic acid, 1 mM EDTA pH 8.0 
 
Ethanol Precipitation 
DNA resuspended in 0.5 x TE or ddH2O was mixed with 3M NaOAc and 100% 
ice cold ethanol (EtOH) in a 1:0.1:2 (v/v/v) ratio. The solution was then snap frozen with 
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N2(l) or frozen at -80C for 30 minutes (min). The DNA was pelleted with centrifugation at 
13,000 x rpm at 4C for 5 min. The supernatant was discarded and the pellet 
resuspended in ice cold 70% EtOH (v/v). The DNA was pelleted by centrifugation at 
13,000 x rpm at 4C for 5 min. The supernatant was removed and the DNA pellet dried 
fully using a SpeedVac (Thermo) on the medium setting for 15-20 min at RT. The DNA 
was resuspended in the appropriate buffer (usually 0.5 x TE) to give the desired 
concentration. 
Buffers:  
0.5 x TE: 5 mM Tris, 0.5 mM EDTA pH 8.0  
 
Salt Fractionation of Chromatin  
Like MNase digestions, the number of cells needed for salt fractionation is 
experimentally determined in order to get clean results that can be compared to other 
treatment conditions. Therefore, cells were resuspended in NP-40 Lysis Buffer for a final 
concentration of ~1 x 106 cells/ml with occasional gentle vortexing for ~5 min on ice. The 
use of a buffer with NP-40 will allow for the isolation of nuclei with intact chromatin. 
Cellular debris was removed by centrifugation at 2,000 x rpm for 5 min at RT. The 
resulting nuclei were washed with SF Wash Buffer two times for 10 min at RT and 
pelleted by centrifugation at 2,000 x rpm for 5 min at RT. Nuclei were resuspended in 
ice-cold 1 x MNase Reaction Buffer and digested with MNase in the experimentally 
determined conditions (described in MNase digestion) and stopped with the addition of 
MNase Stop Mix for a final 2 mM EGTA at RT. Because the salt fractionation is a 
measure of solubility on native chromatin, which needs Mg2+ ions, the MNase stop mix 
uses EGTA instead of EDTA73. Undigested chromatin was pelleted by centrifugation at 
2,000 x rpm for 10 min at 4C and the supernatant collected. The pellet was 
resuspended in SF Buffer 80 with rotation for 2 hours (h) at 4C. Chromatin was again 
pelleted by centrifugation at 2,000 x rpm for 10 min at 4C and the supernatant collected. 
This resuspension and pelleting was repeated with SF Buffer 150 and SF Buffer 600, 
which was rotated overnight (ON) at 4C. The final pellet was resuspended in SF Buffer 
P (fig 2.1). 
The collected supernatants and pellet resuspension were cleaned from any 
precipitates by centrifugation at 14,000 x rpm for 2 min at RT. In order to detect 
differences in the underlying DNA, 20 l of each sample were run on a 3.3% NuSieveTM 
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agarose gel in 1 x TAE, stained with EtBr, and imaged on a Bio-Rad Gel Doc™. The 
differences in protein content were determined through western blot analysis on 20 l of 
each fraction. The supernatants were run on a 4-12% NuPAGE® MES SDS 
polyacrylamide gel (Thermo) in 1 x MES SDS Running Buffer at 200 volts (V) for 35 min.  
Proteins were transferred to a PVDF (polyvinylidene difluoride) membrane in 1 x 
Transfer Buffer at 400 V for 35 min on ice. The membrane was incubated in 1 x Blocking 
Buffer for 1 h at RT with rocking. The membrane was washed thrice in 1 x PBS-T for ~5 
min at RT with rocking. The membrane was blotted with primary antibody overnight at 
4C with rocking (HMGN1: pAb from Active Motif, histone H1: pAb from Active Motif, 
PARP-1: pAb from Active Motif, histone H3: pAb from Abeam). The primary antibody 
was removed and the membrane was washed thrice in 1 x PBS-T for ~5 min at RT with 
rocking. The appropriate secondary antibody with alkaline phosphatase was added in 1 
x PBS-T for 1 h at RT with rocking. The membrane was washed thrice in 1 x PBS-T for 
~5 min at RT with rocking and ECF substrate (GE Healthcare) was added immediately 
before imaging on a Typhoon FLA 9500 from GE Healthcare using the ECF filter. 
Buffers:  
NP-40 Lysis Buffer: 10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.5% NP-40 
(v/v), 0.15 mM spermine, 0.5 mM spermidine, 1 x protease inhibitor cocktail 
SF Wash Buffer: 10 mM Tris-HCl pH 7.4, 15 mM NaCl, 60 mM KCl, 0.15 mM spermine, 
0.5 mM spermidine 
1 x MNase Reaction Buffer: 50 mM Tris-HCl pH 8.0, 1 mM CaCl2, 15 mM NaCl 
MNase Stop Mix: 10 mM EGTA, 1% SDS (v/v) 
SF Buffer 80/150/600: 80/150/600 mM NaCl, 10 mM Tris-HCl pH 7.4, 2 mM MgCl2, 2 
mM EGTA, 0.1% Triton X-100 (v/v), 0.5 mM PMSF (phenylmethylsulfonyl 
fluoride) 
SF Buffer P: 200 mM NaCl, 10 mM Tris-HCl pH 7.4, 1 mM EDTA pH 8.0 
1 x TAE: 40mM Tris, 20 mM acetic acid, 1mM EDTA pH 8.0 
1 x MES SDS Running Buffer: 50 mM MES (2-ethanesulfonic acid), 50 mM Tris, 0.1% 
SDS, 1 mM EDTA pH 8.0, buffer pH 7.3  
1 x Transfer Buffer: 25 mM Tris, 192 mM glycine, 10% methanol (v/v) 
1 x Blocking Buffer: 0.05% milk (w/v), 0.002% Tween-20 (v/v), in phosphate buffered 
saline (Sigma) 
1 x PBS-T: 0.002% Tween-20 (v/v) in phosphate buffered saline (Sigma) 
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Microarray Hybridization 
 Total RNA was isolated from HeLa cells using a miRNAeasy mini kit (Qiagen) 
with manufacturer’s protocol. RNA quality was assessed using a RNA 6000 Nano-
labchip (Bioanalyzer, Agilent) and quantified using OD260 on a Nanodrop 
spectrophotometer (Thermo). The University of Kentucky Microarray core facility used 
Affymetrix protocols to generate labeled cDNA from 100 ng total cellular RNA, they then 
hybridized the cDNA to an Affymetrix Human Transcriptome 2.0ST array (HTA), which 
uses both exon and exon-exon junction probes to measure included/excluded 
exon/regions. HTA arrays were scanned using the Affymetrix 3000 7G scanner and the 
signal intensity of probe hybridization was processed using Command Console software 
version 4.1.2. 
 
Gene Level Analysis 
Signal intensities of the scanned HTA arrays were imported into Partek 
Genomics Suite 6.6 (Partek, MO) using the GCRMA (GC Robust Multi-array Average) 
algorithm. The probe sets were normalized with the Affymetrix® Expression Console 
Software (build 1.3.1.187) with “Gene Level-Default: RMA-Sketch”.  These normalized 
files were then imported into the Affymetrix® Transcriptome Analysis Console (TAC) 2.0 
(build 2.0.0.9). Three conditions, non-treated (NT), 1 µM iAs-treated (iAs-T), and 1 µM 
iAs treated cells with iAs removed for 10 days (iAs-Rev), were created with replicates 
using the “Gene Level Differential Analysis” option. Differentially expressed transcript 
clusters (DETCs) were determined using “Run Analysis”. Since the use of p-value 
cutoffs alone in microarray gene expression studies can lead to the underestimation of 
variance, which results in a large number of falsely positive labeled differentially 
expressed genes (DEGs), a fold change (FC) cutoff was added to the analysis to help 
reduce the false discovery rate (FDR). This selection criterion is consistent with the 
results of the MicroArray Quality Control (MAQC) project which shows the fold change 
cut off enhances reproducibility and the p-value criterion balances sensitivity and 
specificity74. A volcano plot, ANOVA p-value cutoff of 0.05, and a log2 fold change of 
±1.2, as determined by Tukey’ s bi-weight average, was used to determine DETCs 
relative to the NT condition. The log2 cutoff of 1.2 reduced the set to a manageable size, 
resulting in meaningful interpretation with a reduced FDR of 0.05.  
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qRT-PCR 
 In order to confirm the microarray data on DEGs three genes: OPN3 (Opsin3), 
PEX11A (Peroxisomal biogenesis factor 11), and MGMT (O6-methylguanine DNA 
methyltransferase) were subject to quantitative reverse transcription polymerase chain 
reaction (qRT-PCR) to measure relative mRNA levels. With the guidance of IDT’s 
PrimerQuest tool qPCR primers were designed to amplify ~100 bp fragment of the 
selected genes and GAPDH (Glyceraldehyde 3-phosphate dehydrogenase), which acts 
as a control gene (table 2.1). 
 Total RNA was isolated from 60 x 106 BEAS-2B/HeLa cells using Quick RNA kit 
from Zymo according to manufacturer’s protocol. RNA was converted to cDNA with the 
Superscript 3 RT kit (Invitrogen) using manufacturer protocol. The qRT-PCR reactions 
(with 1 x EvaGreen® from Biotium) were run on a CFX96TM Real-Time PCR Detection 
system from Bio-Rad (table 2.2). Changes in gene expression, as fold change relative to 
non-treated was determined by through the 2-CT method (CT = {[treated gene CT – 
treated GAPDH CT] – [non-treated gene CT – non-treated GAPDH])
75. The CT, or 
threshold cycle, is the cycle during which the fluorescence of the sample exceeds the 
background levels75. Significance was determined through a one-tailed homoscedastic 
student’s t-test. 
 
RNA Transcript Alternative Splicing Analysis 
The HTA array data files were normalized as described in gene level analysis. 
Exon probes were summarized into genes and alternative splicing was determined 
through an ANOVA 1-way analysis at the gene level among treatment groups. A p-value 
of < 0.05 identified statistically significant changes in splicing patterns. 
 
Splice Variant Analysis 
Three genes were selected to validate changes in splicing patterns: ABCG2 
(ATP Binding Cassette Subfamily G Member 2), MGP (Matrix Gla Protein), and NCAM2 
(Neural Cell Adhesion Molecule 2). Using the Ensembl genome browser release 75, 
primers were designed to differentiate the isoforms of the selected genes (table 2.1).  
The PCR product (table 2.2) was run on a 3.3% NuSieveTM agarose gel in 1 x 
TBE stained with GelStar™ Nucleic acid Gel stain (Lonza) at 100 V for 2 h. The gels 
were imaged using the ECF filter on a Typhoon FLA 9500 from GE Healthcare and the 
band intensities were quantified using ImageQuantTL. 
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Buffers:  
1 x TBE: 89 mM Tris, 89 mM boric acid, 2 mM EDTA pH 8.0 
 
Chromatin Architectural Protein Purification 
Drosophila histone H1, Drosophila HMGD1 (high mobility group 1), and human 
MeCP2 (methyl CpG binding protein 2) cDNAs were cloned into the Champion pET 
SUMO system (Invitrogen) for protein expression which places a 6 x His-SUMO tag onto 
the N-terminus of the protein. Due to incomplete translation, the 6 x His-SUMO-MeCP2 
was further cloned into the pTXB1 Vector (NEB) to place a C-terminal intein self-cleaving 
chitin binding domain tag to select for fully translated proteins. 
All proteins were expressed in E. coli in LB Broth with either 50 g/ml Kanamycin 
(histone H1, HMGD1) or 100 g/ml Ampicillin (MeCP2). Protein expression was induced 
with 1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) when the culture reached an 
OD280 ~0.6. Bacteria were then grown for 3 h at 37°C (HMGD1) or for 16 h at 16C 
(histone H1 and MeCP2) and pelleted by centrifugation at 5,000 x g for 10 min at 4C. 
Cell pellets were then used immediately or stored at -20°C until protein purification. 
The cell pellet of HMGD1 was resuspended in Wash Buffer A with 1 x protease 
inhibitor cocktail and 5 mg lysozyme and left on ice for 20 min. Cells were lysed with 3 
rounds of sonication (20 second pulse at 65% with 3 seconds off for a total of 1 min). 
Cellular debris was pelleted by centrifugation of cellular lysate at 14,000 x g for 15 min at 
RT. The Supernatant was added to 5 ml of Ni2+ resin slurry (Sigma) with rotation for 30 
min at 4°C. Purified protein bound to the Ni2+ was removed from crude cell lysate by 
centrifugation at 1,000 x g for 5 min at RT. The Ni2+ slurry was washed thrice with 35 ml 
Wash Buffer A and rotation for 5 min at 4°C. The His-SUMO-HMGD1 protein was eluted 
from Ni2+ with Buffer E1 and rotation for 5 min at 4°C. The histone H1 or MeCP2 cell 
pellet was resuspended in 35 ml Lysis Buffer A and the cells were lysed with a French 
Press. The crude homogenate was centrifuged at 30,000 x g for 45 min at 4C and the 
supernatant filtered through a 10 ml Ni2+ column (His Select resin from Sigma) by 
gravity. The column was washed twice with 100 ml of Wash Buffer B and then Wash 
Buffer C until the wash fraction exhibited an OD280 of 0.02 or less. Bound proteins were 
then eluted with Buffer E2. 
The His-SUMO tag was removed from the purified proteins through ON digestion 
with SUMO protease, a kind gift from the Gentry lab, (50: 1 purified protein [v/v]) in 
dialysis against 4 liters (L) of SUMO Buffer at 4C with stirring. HMGD1 was further 
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purified on a HiTrap Heparin HP column (GE Healthcare) with Heparin Buffers in 200 
mM NaCl steps (HMGD1 eluted with Heparin Buffer-400). Histone H1 and MeCP2 were 
further purified on a Mono S cation exchange column (GE Healthcare) using a 150 mM–
800 mM NaCl gradient in 25 mM Tris-HCl pH 8.0 (histone H1 and MeCP2 both eluted at 
~600 mM NaCl). MeCP2 was further purified on a chitin column (NEB). MeCP2 was 
washed with Chitin Wash Buffer, and eluted with Buffer E3.  
Purified proteins were moved to their respective storage buffers through ON 
dialysis at 4C, which differed mainly in NaCl concentration for protein stability, and 
concentrated to ~0.5–1 mg/ml with Amicon Ultra Centrifugal Filters (Millipore).  
Buffers:  
LB Broth: 10 grams (g) bacto-tryptone, 5 g yeast extract, 10 g NaCl in ddH2O for final 1 
liter  
Wash Buffer A: 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 15 mM imidazole 
Buffer E1: 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 300 mM imidazole 
Lysis Buffer A: 25 mM Tris-HCl pH 8.0, 150 mM NaCl/200 mM NaCl for MeCP2, 1 mM 
PMSF, 5 mM imidazole 
Wash Buffer B: 150 mM NaCl/200 mM NaCl for MeCP2, 25 mM Tris-HCl pH 8.0  
Wash Buffer C: 25 mM Tris-HCl pH 8.0, 150 mM NaCl/200 mM NaCl for MeCP2, 5 mM 
imidazole 
Buffer E2: 125 mM imidazole, 25 mM Tris-HCl pH 8.0, 200 mM NaCl 
SUMO Buffer: 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM DTT 
Heparin Buffers: 200/400/600/800/1000 mM NaCl, 20 mM Tris-HCl pH 8.0 
Chitin Wash Buffer: 1 M NaCl, potassium phosphate buffer pH 7.5 
Buffer E3: 50 mM DTT, 200 mM NaCl in potassium phosphate buffer pH 7.5 
Storage Buffer Histone H: 25 mM potassium phosphate pH 7.5, 300 mM NaCl  
Storage Buffer M: 10 mM potassium phosphate buffer pH 7.5, 300 mM NaCl, trace DTT 
Storage Buffer D: 400 mM NaCl, 20 mM Tris-HCl pH 8.0,  20% glycerol 
 
Histone Octamer Labeling 
 In order to select which reside the Cy5 label attaches to we used maleamide 
chemistry to target the sulfhydryl group on cysteine residues, which are not present in 
histone H2A. Therefore, our histone octamers are made with a histone H2A protein that 
has a lysine (K) to cysteine (C) mutation on residue 119 (H2A K119C). Lyophilized 
histone octamer proteins (H2A K119C, H2B, H3, and H4) were unfolded in Unfolding 
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Buffer at a concentration of 5 mg/ml for 1-3 hours at RT. OD280 was measured for each 
unfolded histone to determine concentration using a Nanodrop Spectrophotometer 
(Thermo). Histones were combined in a molar ratio of 1.2 H2A K119C: 1.2 H2B: 1 H3: 1 
H4 and refolded by double dialysis against 4 L Refolding Buffer at 4C, the first dialysis 
was for a minimum of 8 hours and the ON. The octamer was brought to 1 mg/ml in 
Labeling Buffer. Cy5 maleimide mono-reactive dye (GE Healthcare) was resuspended in 
anhydrous dimethylformamide (DMF) drop wise, with mixing, for a final 0.35 mg/ml 
concentration. Cy5 was added slowly to the folded histone octamer and the reaction was 
rotated for 2 h at RT followed by rotation ON at 4C. The reaction was terminated with 
10 mM DTT and purified with fast protein liquid chromatography (FPLC) over a 
Superdex 200 (GE Healthcare) gel filtration column to remove excess histone dimer, 
histone tetramer, and unbound Cy5 dye. The purity of each octamer was confirmed by 
performing 18% SDS-PAGE in 1 x SDS Running Buffer at 200 V for 45 min followed by 
staining with Coomassie Brilliant Blue Stain, which stains all proteins present in the 
sample. Labeling efficiency was determined by OD280 (protein amount) and OD650 (Cy5 
amount) as determined by a Nanodrop Spectrophotometer (Thermo). 
 Histone octamer mutagenesis, expression, purification, folding, and labeling were 
performed by the Poirier lab at The Ohio State University. 
Buffers:  
Unfolding Buffer: 7 M guandinium, 10 mM DTT, 20 mM Tris-HCl pH 7.5 
Refolding Buffer: 2 M NaCl, 200 mM HEPES pH 7.1, 1 mM EDTA pH 8.0 
Labeling Buffer: 2 M NaCl, 200 mM HEPES pH 7.1, 1 mM EDTA pH 8.0, 0.7 mM TCEP 
(Tris [2-carboxyethyl] phosphine) pH 7.1 
1 x SDS Running Buffer: 25 mM Tris, 192 mM glycine, 0.1% SDS (v/v)  
Coomassie Brilliant Blue Stain: 0.6 g coomassie brilliant blue powder, 90 ml ddH2O, 90 
ml methanol, 20 ml glacial acetic acid 
 
DNA Labeling 
 As with our fluorescent labeling of the histone octamer, we used maleamide 
chemistry to select which bp the Cy3 label attaches. To this end we created a primer 
with an internal Amino C6 dT (AmC6dT) (Sigma) (table 2.1). This primer was purified 
from any residual amines from the synthesis with three rounds of EtOH precipitation 
(described in ethanol precipitation). 1 mg of Cy3 maleimide mono-reactive dye (GE 
Healthcare) was resuspended in 16 l anhydrous dimethyl sulfoxide (DMSO) slowly with 
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at least 100 rounds of gentle pipetting to ensure full mixture without adding bubbles to 
the solution. The recovered 0.03-0.06 mol of primer in 100 mM sodium tetraborate 
(Na2B4O7·10H2O) was mixed with 4 l of the resuspended Cy3 with rotation ON at RT. 
The reaction was stopped and excess dye removed with three rounds of EtOH 
precipitation (described in ethanol precipitation). The labeled primer was purified with 
high pressure liquid chromatography (HPLC) with a 10% acetic nitrile/90% TEAA to 30% 
acetic nitrile/70% TEAA gradient at 0.5 ml/min for 24 min on a C18 column.  
 The Cy3 labeled purified forward primer was paired with a reverse primer (table 
2.1) for PCR using the Gal4(L) plasmid, a kind gift from the Poirier Lab, as a template 
(table 2.2). The PCR generated a Cy3 labeled 247 bp mononucleosome construct (table 
2.3) based on the ‘601’ nucleosome positioning sequence (NPS)76 that contains a Gal4 
binding site (table 2.3) and 50 bp entry and exit linker DNA (table 2.3) (fig 2.2a). The Cy3 
labeled mononucleosomal construct was purified by FPLC over a MonoQ anion 
exchange column using a 0.75 ml/min gradient of 80% TE0/20% TE1000 to 20% TE0/80% 
TE1000 over 30 min. The DNA concentration and labeling efficiency were determined by 
comparing the OD260 (DNA amount) and OD550 (Cy3 amount) as detected on a 
Nanodrop spectrophotometer (Thermo).  
Buffers:  
TEAA: 0.1 M triethylamine acetic acid pH 7.0, 1 mM EDTA pH 8.0 
TE0: 25 mM Tris, 1 mM EDTA pH 8.0 
TE1000: 1000 mM NaCl, 25 mM Tris, 1 mM EDTA pH 8.0 
 
Chromatin Array DNA Purification 
E. coli transformed with the 17mer plasmid, a kind gift from the Poirier lab, was 
grown in 500 ml LB Broth with 100 g/ml Ampicillin at 37C ON with shaking. The 
plasmid was purified using the PureLink® HiPure Plasmid Maxiprep Kit (Invitrogen) and 
manufacturer protocols. 1 g of purified plasmid was digested with 0.25 U DdeI in 1 x 
NEB Buffer 3 at 37C for at least 6 h. The digestion was boosted with 0.25 U DdeI for 
ON digestion at 37C. The digestion was stopped by incubation at 65C for 20 min. 
Complete digestion was confirmed by 0.7% agarose gel electrophoresis with 0.1 x 
GelStarTM Nucleic Acid Gel Stain (Lonza) in 1 x TAE at 80 V for 2 h and imaging on a 
Typhoon FLA 9500 from GE Healthcare using the ECF filter. The digested DNA was 
purified with 2 rounds of phenol/chloroform purification followed by an EtOH precipitation 
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(described in ethanol precipitation). Purified DdeI digested plasmid was resuspended in 
0.5 x TE for the desired concentration and stored at -80C until use.  
Buffers:  
LB broth: 10 grams (g) bacto-tryptone, 5 g yeast extract, 10 g NaCl in ddH2O for final 1 
liter  
1 x TAE: 40 mM Tris, 20 mM acetic acid, 1 mM EDTA pH 8.0 
0.5 x TE: 5 mM Tris, 0.5 mM EDTA pH 8.0 
 
Dialysis Tubing Preparation 
The process of generating and preserving the dialysis tubing can result in the 
tubing having trace heavy metals and preservative contaminants, which can interfere 
with nucleosome formation. Therefore, these contaminants must be removed before 
use. Tubing, cut to desired size, was boiled for 10 min in 2% sodium bicarbonate in 0.5 x 
TE (w/v), rinsed with ddH2O, and boiled again for 10 min in 1 mM EDTA pH 8.0 in 0.5 x 
TE. Once prepared the tubing was stored in 50% EtOH (v/v) at 4C. The sodium 
bicarbonate removes the preservatives on the tubing, the EDTA removes any trace 
heavy metals, and 50% ethanol prevents microbial growth during storage. 
Buffers: 
0.5 x TE: 5 mM Tris, 0.5 mM EDTA pH 8.0 
 
Native Polyacrylamide Gel Electrophoresis 
 Acrylamide gels without the denaturant SDS allow binding events to remain 
intact. Therefore, the mobility will be determined by the size of the overall complex, thus, 
free DNA, nucleosomal DNA centered on the histone octamer, and nucleosomal DNA off 
center on the histone octamer. Without the uniform charge provided by SDS, charge 
impurities from the solidifying reaction between APS and TEMED are found throughout 
the gel and will distort the mobility of the complexes77. Accordingly, the native gels must 
be pre-run in order to remove these impurities and make the gel a uniform charge77. The 
gel has been sufficiently pre-run when the resistance has dropped by half77, however, if 
time is not a factor, 300 V for 1 h is used as the standard. 
 If samples are not fixed the complexes may dissociate in the wells prior to the 
complexes entering the gel. To minimize the time the reactions are within the well, where 
they are most likely to dissociate77, the samples are loaded onto a running gel. To further 
minimize the likelihood of the dissociation of the complexes within the gel, the gel can 
18 
 
incorporate some aspects of the binding reaction buffer to stabilize the complex. 
Therefore, the native gels used to study chromatosome formation have glycerol which is 
present in Nuc Buffer 130. Because glycerol can interact with boric acid, the buffer for 
these gels contains taurine instead. Therefore, two types of native gels were used, with 
and without glycerol (table 2.4). 
 
Sucrose Gradient 
 Sucrose gradients must be made immediately before use to prevent diffusion, 
and therefore loss of gradient. Gradients were made on a BioComp model 108 gradient 
masterTM according to manufacturer protocol. Since mononucleosome gradients were 
centrifuged in a SW-41ti rotor the 30% sucrose in 0.5 x TE (w/v) and 5% sucrose in 0.5 x 
TE (v/v using 30% sucrose in 0.5 x TE) was rotated on the gradient master platform for 1 
min 36 s at an 81.5 angle at speed 19. The 17mer gradients were run in an SW-40ti 
rotor and therefore the 40% sucrose in 0.5 x TE (w/v) and 5% sucrose in 0.5 x TE (v/v 
using 40% sucrose in 0.5 x TE) was rotated at speed 19 at an 81.5 angle for 1 min 14 s. 
Once gradients were made they were chilled at 4C for 1 h before sample was added to 
the top (5%) of the gradient. 
Buffers:  
0.5 x TE: 5 mM Tris, 0.5 mM EDTA pH 8.0 
 
Nucleosome Reconstitution, Purification, and Positioning  
 Mononucleosome reconstitutions using purified reagents exploits the charge 
buffering property of NaCl on the nucleosomes, which is stabilized by the opposing 
charges of DNA and histone octamers. To form mononucleosomes, DNA must be 
present in molar excess to histone octamer to prevent histone octamer aggregation on 
the DNA. Therefore, a standard mononucleosome reconstitution uses a molar ratio of 1 
purified DNA construct (described in DNA labeling): 0.8 histone octamer (described in 
histone octamer labeling) in 2 x Recon Reaction Buffer. The reaction should aim for a 
final DNA concentration of 0.4 mg/ml in Recon Buffer A. The DNA: histone octamer ratio 
can be increased based on experimental reconstitutions as long as free DNA is 
observed; furthermore, if the DNA/histone octamer is not concentrated enough to 
achieve the final 0.4 mg/ml DNA concentration the lowest possible 2 x Recon Reaction 
Buffer volume should be used to keep the recon as close to this concentration as 
possible. The reactions were placed in dialysis buttons made with prepared 6,000-8,000 
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MW dialysis tubing (discussed in dialysis tubing preparation). In order to prevent 
‘shocking’ the reaction with a dramatic change in NaCl concentration the buttons were 
placed in 50 ml Recon Buffer A in prepared 6,000-8,000 MW dialysis tubing and dialyzed 
twice against 4 L Recon Buffer B with the first dialysis taking place over a minimum of 6 
h and the second ON, all at 4C with stirring.  
 Mononucleosomes were purified from excess histone octamer/off target products 
on a 5-30% sucrose gradient in 0.5 x TE (described in Sucrose Gradients). Gradients 
were centrifuged at 41,000 x rpm for 22 h at 4C in a SW-41ti rotor in a Beckman Optima 
XPN-90 Ultracentrifuge with minimum acceleration and minimum brake. Post-run, 500 l 
fractions were collected from the bottom of the gradient at 1.6 ml/min using a Peristaltic 
Pump P-1 from GE Healthcare. 10 l of each fraction was run on a 5% native 
polyacrylamide gel without glycerol (table 2.4) in 0.3 x TBE (run conditions discussed in 
native polyacrylamide gels). Gels were imaged on a Typhoon FLA 9500 from GE 
Healthcare using the Cy3 filter (fig 2.3a). The fractions containing solely 
mononucleosomes were pooled and buffer exchanged into 0.5 x TE using a 2 ml 30,000 
NMWL Amicon Ultra centrifugal filter (Millipore) spun at 2,500 x g at 4C for a time to get 
the desired ~ 50 l volume. The nucleosomes were washed thrice with 0.5 x TE to 
ensure sucrose removal. Mononucleosome concentration was determined by DNA 
concentration using OD260 (DNA) and, if appropriate, OD550 (Cy3) as measured on a 
Nanodrop Spectrophotometer (Thermo). Purified mononucleosomes were stored in 0.5 x 
TE on ice until use. 
 Due to the dynamic nature of nucleosomes the histone octamer can move from 
the most thermodynamically stable position (the histone octamer centered on the 601 
NPS) during storage78. Therefore, immediately before experiments 50 nM 
mononucleosomes, in Nuc Buffer 130, were heated at 55C for 2 h to favor the most 
thermodynamically stable nucleosome position (fig 2.3b)78. 
Buffers:  
2 x Recon Reaction Buffer: 4 M NaCl, 2 mM BZA, 10 mM Tris, 1 mM EDTA pH 8.0 
Recon Buffer A: 2 M NaCl, 1 mM BZA, 5 mM Tris, 0.5 mM EDTA pH 8.0  
Recon Buffer B: 1 mM BZA, 5 mM Tris, 0.5 mM EDTA pH 8.0  
0.3 x TBE: 26.7 mM Tris, 26.7 mM boric acid, 0.6 mM EDTA pH 8.0 
0.5 x TE: 5 mM Tris, 0.5 mM EDTA pH 8.0 
Nuc Buffer 130: 130 mM NaCl, 10% glycerol, 10 mM Tris-HCl pH 8.0, 0.005% (v/v) 
Tween-20 in 0.5 x TE 
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Chromatin Reconstitution, Purification, and Positioning  
 Like the mononucleosome reconstitution, the reconstitution of longer chromatin 
structures from purified reagents utilizes the opposing charges of the protein and DNA 
and NaCl as a charge buffer. To ensure each NPS76 is wrapped around a histone 
octamer, thus achieving array saturation, the reaction contains molar excess histone 
octamer. However, since the array has linker regions between each NPS (fig 2.2b) the 
excess histone octamer could also be incorporated into the array, which would lead to 
oversaturation and heterogeneous chromatin structures. Therefore, ‘buffering’ DNA 
capable of being wrapped into nucleosomes must also be present in the reaction to act 
as a histone octamer binding pool. For this reason, the DdeI digested 17mer plasmid 
generates the array DNA and seven buffer DNAs composed of: 653 bp, 535 bp, 421 bp, 
404 bp, 245 bp, 230 bp, and 161 bp (table 2.3). 
 Purified DdeI digested 17mer plasmid (described in chromatin array DNA 
purification), wild type human histone octamer (purchased from the Luger laboratory), 
and specified CAP were combined in 2 x Recon Reaction Buffer at a molar ratio of 1 
DdeI digested 17mer plasmid: 23 histone octamers: 23 CAPs. Since each plasmid 
contains 17 NPSs this results in a 1 NPS: 1.4 histone octamer: 1.4 CAP ratio which is 
sufficient to bring about array saturation79. As with the mononucleosomes, the reactions, 
which were placed in buttons made with 6,000-8,000 MW dialysis tubing (described in 
dialysis tubing preparation), were placed in 50 ml Recon Buffer A in 6,000-8,000 MW 
dialysis tubing (described in dialysis tubing preparation) and dialyzed twice against 4 L 
Recon Buffer B with the first dialysis taking place over a minimum of 6 h and the second 
ON, all at 4C with stirring. 
 Reconstituted chromatin arrays were purified from excess buffering reactants 
(free DNA and proteins) on a 5-40% sucrose gradient in 0.5 x TE (described in sucrose 
gradient). The arrays were centrifuged at 40,000 x rpm for 8 h at 4C in a SW-40ti rotor 
in Beckman Optima XPN-90 Ultracentrifuge with minimum acceleration and brake. Post-
run, 400 l fractions were collected at 1.3 ml/min using a Peristaltic Pump P-1 (GE 
Healthcare). 10 l of each fraction were run on a 0.7% agarose gel with 0.5 x GelStarTM 
Nucleic Acid Gel Stain (Lonza) in 1 x TAE at 250 V for 35 min (fig 2.4a).  Gels were 
imaged using the ECF filter on a Typhoon FLA 9500 from GE Healthcare. The fractions 
containing solely fully reconstituted chromatin were pooled and buffer exchanged into 
0.5 x TE using a 15 ml 30,000 NMWL Amicon Ultra centrifugal filter (Millipore) with 
centrifugation at 2,500 x g at 4C for a time that resulted in ~ 500 l sample. The 
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chromatin was washed with 0.5 x TE thrice in the Amicon filter with centrifugation at 
2,500 x g at 4C to ensure all sucrose was removed from the sample. The final wash 
was extended so that the final volume was ~ 200 l or less. Chromatin concentration 
was measured by DNA content as determined by OD260 as measured by a Nanodrop 
Spectrophotometer (Thermo). The chromatin was brought to the working 50 ng/l 
concentration through subsequent rounds of centrifugation with the appropriate sized 
30,000 NMWL Amicon Ultra centrifugal filter (Millipore) and/or addition of 0.5 x TE. 
Purified arrays were stored in 0.5 x TE and kept on ice until use (fig 2.4b). 
 As with the mononucleosomes, chromatin is dynamic and therefore the 
nucleosomes and CAPs can reposition themselves so that they are not centered on a 
positioning sequence during storage. Thus, before restriction enzyme digest, 25 ng of 
purified chromatin was exposed to 300 nM ISWI (a gift from the Kadonaga lab) with 2 
mM ATP in RED Buffer 1 for 1 h at 27C.  Centering of the histone octamers and CAPs 
on the positioning sequences was confirmed with AvaI digest. AvaI digest sites were 
incorporated into each linker region of the array and completely centered arrays will 
therefore result in a single nucleosomal band and non-centered proteins will result in a 
nucleosomal ladder (fig 2.4c). After centering with ISWI 25 ng of chromatin array (based 
on DNA content) was digested with 3.75 U AvaI (NEB) in AvaI Reaction Buffer for 1 h at 
37C. The reaction was stopped by incubation for 20 min at 80C. The resulting 
complexes were fixed with a final 0.25% glutaraldehyde (v/v) on ice for 30 min and 
visualized using a pre-run 5% native polyacrylamide gel without glycerol (table 2.4) in 
0.3 x TBE at 300 V for 1.5 h (detailed instruction on native gel electrophoresis in native 
polyacrylamide gel electrophoresis). Gels were stained post-run by submersion under 
0.5 x GelStarTM Nucleic Acid Gel Stain (Lonza) in 0.3 x TBE for 1 h and imaged on a 
Typhoon FLA 9500 from GE Healthcare using the ECF filter (fig 2.4d).  
Buffers:  
2 x Recon Reaction Buffer: 4 M NaCl, 2 mM BZA, 10 mM Tris, 1 mM EDTA pH 8.0 
Recon Buffer A: 2 M NaCl, 1 mM BZA, 5 mM Tris, 0.5 mM EDTA pH 8.0 
Recon Buffer B: 1 mM BZA, 5 mM Tris, 0.5 mM EDTA pH 8.0 
1 x TAE: 40 mM Tris, 20 mM acetic acid, 1mM EDTA pH 8.0 
0.5 x TE: 5 mM Tris, 0.5 mM EDTA pH 8.0 
RED Buffer 1: 1 mM MgCl2, 100 mM NaCl, 50 mM Tris-HCl pH 8.0,1 mM DTT, 1 x BSA 
AvaI Reaction Buffer: 50 mM potassium acetate, 20 mM Tris-acetate, 10 mM 
magnesium acetate, 1 mM DTT, buffer pH 7.9 
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0.3 x TBE: 26.7 mM Tris, 26.7 mM boric acid, 0.6 mM EDTA pH 8.0 
 
Quality Control of Chromatin Arrays 
 In addition to confirming the correct positioning of the histone octamers and 
CAPs, AvaI digestions is used to confirm array saturation by measuring the intensity of 
nucleosome DNA to free DNA. Therefore the band intensities of the AvaI digested 
chromatin arrays (described in chromatin reconstitution, purification, and positioning) 
were quantified using ImageQuantTL (fig 2.4d). Keeping in mind that GelStarTM Nucleic 
Acid Gel Stain (Lonza) stains naked DNA ~six times more efficiently than nucleosomal 
DNA80, we determined that all the arrays were equally saturated at ~ 90% (fig 2.4d). 
 We also validated that the reconstituted chromatin arrays were CAP-specific by 
SDS-polyacrylamide gel electrophoresis. 50 ng of purified chromatin and chromatosome 
arrays (based on DNA content) were precipitated with 5 mM MgCl2 in 1 x SDS Loading 
Buffer for 10 min at 90C. Proteins were visualized with 18% SDS-PAGE in 1 x SDS 
Running Buffer at 200 V for 45 min (fig 2.4e). The gel was stained with Coomassie 
Brilliant Blue Protein Stain to detect total protein content of the arrays. The gels were 
imaged and the resulting band intensities measured using an Odyssey® Infra-Red 
Imaging System (LI-COR).  
Buffers:  
1 x SDS Loading Buffer: 50 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 0.1% (w/v), 
bromophenol blue, 10% (v/v) glycerol, 100 mM DTT  
1 x SDS Running Buffer: 25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS  
Coomassie Brilliant Blue Stain: 0.6 g coomassie brilliant blue powder, 90 ml ddH2O, 90 
ml methanol, 20 ml glacial acetic acid 
 
Electromobility Gel Shift Assays 
Due to the charge based interactions between the DNA and histone 
octamer/CAP NaCl concentration can have direct consequence on the affinity of the 
binding reactions. Therefore, purified nucleosomes and purified CAPs, were diluted from 
the storage ‘stock’ in Nuc Buffer 130 to limit the difference in NaCl concentration 
between each reaction and CAP sample. Importantly, both nucleosomes and CAP 
proteins are more stable in higher concentrations in their respective storage buffers, and 
therefore the dilutions must be done immediately before the experiment.  
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CAPs (0–250 nM) were incubated with 5 nM centered mononucleosomes (fig 
2.3b) in 20 l (final volume) Nuc Buffer 130 for 3 min on ice. The reactions were 
visualized on a pre-run 5% native polyacrylamide gel with glycerol (table 2.4) in 0.3 x 
TTE at 250 V for 105 min (detailed instruction on native gel electrophoresis in native 
polyacrylamide gel electrophoresis). Gels were stained post run by submersion under 
0.5 x GelStarTM Nucleic Acid Gel Stain (Lonza) in 0.3 x TTE, which stains naked DNA 
more efficiently than nucleosomal DNA80, and imaged on a Typhoon FLA 9500 from GE 
Healthcare using the ECF filter.  
Buffers:  
Nuc Buffer 130: 130 mM NaCl, 10% glycerol, 10 mM Tris-HCl pH 8.0, 0.005% (v/v) 
Tween-20 in 0.5 x TE 
0.3 x TTE: 26.7 mM Tris, 8.6 mM taurine, 0.15 mM EDTA pH 8.0 
 
Förster Resonance Energy Transfer (FRET) Measurements and Efficiency Analysis 
As with the gel shift experiments, keeping NaCl concentration steady is essential 
for accurate FRET measurements and analysis, as a change in 40 mM NaCl is enough 
to change the FRET efficiency independent of other factors10,12. Therefore, the purified 
nucleosomes and CAPs were diluted in the reaction buffer, either Nuc Buffer 130 or 0.5 
x TE. Furthermore, the absorbance of the reaction buffer, proteins, and DNA can also 
influence the signal intensity at multiple wavelengths. Therefore, multiple control 
measurements were collected to ensure the change in FRET signal was due to a 
change in distance between the labels and not due to a difference in CAP/Gal4 1-147 
concentration including the emission signal of the reaction buffer when excited at 510 
and 610 nm, the emission signal of the protein in the reaction buffer when excited at 510 
and 610 nm. 
20 l reactions containing centered 5 nM Cy3-Cy5 labeled nucleosomes (fig 
2.3)10,81, CAP, and/or Gal4 1-147, the DNA binding region of Gal4, were incubated for at 
least 3 min on ice. The reactions were then excited at 510 nm (Cy3-donor) and 610 nm 
(Cy5-acceptor) and the emission spectra measured from 530–750 nm and 630–750 nm 
respectively using a Fluoromax-4 photon-counting steady state fluorometer (Horiba) at 
RT. MATLAB R2013b was used to integrate the acceptor emission (550-580 nm) and 
donor emission (656–674 nm) data to determine FRET efficiency using the RatioA 
method (FRET Efficiency = 2[εA610{A510-D510}/{A610} − {εA510}] / [{εD510}{fractional labeling 
of D}]). The prefactor of 2 reflects the presence of two acceptor molecules (Cy5 labeled 
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H2A) per donor molecule (Cy3 labeled DNA K119C), εA610 is the extinction coefficient of 
Cy3 at 610 nm, A510 is the emission of Cy3 when excited with 510 nm light, D510 is the 
emission of Cy5 when excited at 510 nm, A610 is the emission of Cy3 when excited at 
610 nm, εA510 is the extinction coefficient of Cy3 at 510 nm, and εD510 is the extinction 
coefficient of Cy5 at 510 nm. All measurements were taken in duplicate or triplicate and 
standard deviation used as a measure of uncertainty. Significance was determined 
through a one-tailed homoscedastic student’s t-test. 
Buffers:  
Nuc Buffer 130: 130 mM NaCl, 10% glycerol, 10 mM Tris-HCl pH 8.0, 0.005% (v/v) 
Tween-20 in 0.5 x TE 
0.5 x TE: 5 mM Tris, 0.5 mM EDTA pH 8.0 
 
Protein Affinity Determination  
 Protein binding, as measured by a change in FRET efficiency, was calculated 
using a Hill binding curve that plots the response as a function of protein concentration, 
which is on a log10 axis. SigmaPlot Version 13.0 was used to fit the FRET efficiency 
measurements to a Hill binding curve with and without the Hill coefficient (chromatosome 
formation = Emin + [Emax − Emin]/[1 + {[titrant]/S1/2}
(-Hill coefficient)]; Gal4 1-147 binding = Emin + 
[Emax − Emin]/[1 + {[titrant]/S1/2}
(Hill coefficient)]).  Emin is the minimum FRET efficiency 
measured, Emax is the maximum FRET efficiency measured, [titrant] is the concentration 
of titrant in nM, S1/2 is the concentration of titrant in nM needed to bring about half the 
change in FRET efficiency, and the Hill coefficient a measure of binding cooperativity 
with n>1 indicative of positive cooperativity, n=1 indicative of non-cooperative binding, 
and n<1 indicative of negative cooperativity. 
 
Restriction Enzyme DNA Accessibility Assay 
 100 ng of the chromatin array based on DNA amount (188.7 ng DdeI digested 
plasmid contains 100 ng of the array DNA), was digested with either 40 U of BamHI 
(NEB) for 1 h or 5 U PstI for 15 min in RED Buffer 2 at 37C. Since both restriction 
enzymes need MgCl2 as a cofactor, reactions were stopped with a final 1.5 mM EDTA 
pH 8.0 immediately followed by digestion with 12 mg Proteinase K for 1 h at 37C. The 
resulting DNA was run on a 1% agarose gel with 0.2 x GelStarTM Nucleic Acid Gel Stain 
(Lonza) in 1 x TAE at 100 V for 1 h and imaged on a Typhoon FLA 9500 from GE 
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Healthcare using the ECF filter. Band intensities were quantified using ImageQuantTL. 
Significance was determined through a one-tailed homoscedastic student’s t-test. 
Buffers:  
RED Buffer 2: 100 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM DTT, 1 mM MgCl2 
1 x TAE: 40 mM Tris, 20 mM acetic acid, 1 mM EDTA pH 8.0 
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Table 2.1: Primers for PCR Amplification 
qRT-PCR 
Gene     Sequence 
OPN3 
F primer GATCTGCTTCTTGGTGGTTAATG 
  R primer CTGGATTGTATACAGTGTTCGATTT 
PEX11A 
F primer CTCCTGGACACAGTGAAGAAC 
  R primer CAAGACCTCCAAGTCCAATGA 
MGMT 
F primer GCCTGGCTGAATGCCTATT 
  R primer CTGTCTGGTGAACGACTCTTG 
GAPDH 
F primer ATGACATCAAGAAGGTGGTGAA 
  R primer GCTGTTGAAGTCAGAGGAGAC 
Splice Variant Analysis 
Gene 
Primer 
Set # 
 Sequence 
ABCG2 
1 
F primer ACTCCCACTGAGATTGAGAGA 
R primer GGTAGAAAGCCACTCTTCAGTT 
2 
F primer GCTAGGTCAGACGAGAAAGATAAA 
R primer GACAAGGTAGAAAGCCACTCTT 
MGP 
 
F primer TCACATGAAAGCATGGAATCTT 
R primer CGCTTCCTGAAGTAGCGATTA 
NCAM2 
 
F primer CTACTTCAGCACATGGAACTCT 
R primer GTGTTTGTCCTTTGGCATCTG 
Mononucleosome 
Const-
ruct 
Modification Sequence 
50(3)-
Gal4-
50 
AmC6 F primer 
AGCTTGTCGACGAATTCAGATCATAAGGAGGACACTGGGA
CA[AmC6dT]GCATCGG 
  R primer 
CGGATCCAGAATTCGTGATTGTAGCGTCAACTCACTGCCC
TATGC 
24-24 
F primer TCAACTCACTGCCCTATGC 
  R primer GGAGGACACTGGGACATG 
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Table 2.2: PCR Programs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
qRT-PCR 
# of cycles temperature time 
1 94°C 3:00 
40 
94°C 0:45 
57.3°C 0:30 
72.0°C 2:00 
Plate Read 
1 65-95°C Melt Curve 
Mononucleosome PCR 
# of cycles temperature time 
35 
95°C 1:00 
60°C 0:45 
72°C 1:00 
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Table 2.3: Sequences of DNA Constructs 
Mononucleosome Construct 
Full 
Seque-
nce 
agcttgtcgacgaattcagatcataaggaggacactgggacatgcatcggctggagaccggagggctgccctccggt
caattggtcgtagcaagctctagcaccgcttaaacgcacgtacgcgctgtcccccgcgttttaaccgccaaggggatta
ctccctagtctccaggcacgtgtcagatatatacatcctgtataatgcatagggcagtgagttgacgctacaatcacgaat
tctggatccg 
Gal4 
Bind. 
ccggagggctgccctccgg 
Entry agcttgtcgacgaattcagatcataaggaggacactgggacatgcatcgg 
Exit ataatgcatagggcagtgagttgacgctacaatcacgaattctggatccg 
Chromatin Array Construct 
Chrom-
atin 
Array 
tcagcccgggaattcagagctcctcgggatgcatcccgccctggagaatcttggtgccgaagccgctcaattggtcgta
gcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaagaggattactccccagtctc
caggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctggagaatcttggtgccgaa
gccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaaga
ggattactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctgg
agaatcttggtgccgaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccg
cgttttaaccgccaagaggattactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgg
gatgcatcccgccctggagaatcttggtgccgaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcac
gtaagggctgtcccccgcgttttaaccgccaagaggattactccccagtctccaggcacgcgtcagatatatacatcctg
tgcatgtattgaactcgggatgcatcccgccctggagaatcttggtgccgaagccgctcaattggtcgtagcaagctcta
ccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaagaggattactccccagtctccaggcacgc
gtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctggagaatcttggtgccgaagccgctcaat
tggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaagaggattactccc
cagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctggagaatcttggt
gccgaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccg
ccaagaggattactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatccc
gccctggagaatcttggtgccgaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctg
tcccccgcgttttaaccgccaagaggattactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattg
aactcgggagatcttgatcactgcagaagcttggtgccggggccgctcaattggtcgtagcaagctctggatccgcttga
tcgaacgtacgcgctgtcccccgcgttttaaacgccaaggggattactccctagtctccaggcacgtgtcagatatatac
atcctgtcggaccgagctcctcgggatgcatcccgccctggagaatcttggtgccgaagccgctcaattggtcgtagca
agctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaagaggattactccccagtctccag
gcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctggagaatcttggtgccgaagcc
gctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaagagga
ttactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctggaga
atcttggtgccgaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgtt
ttaaccgccaagaggattactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggat
gcatcccgccctggagaatcttggtgccgaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgta
agggctgtcccccgcgttttaaccgccaagaggattactccccagtctccaggcacgcgtcagatatatacatcctgtgc
atgtattgaactcgggatgcatcccgccctggagaatcttggtgccgaagccgctcaattggtcgtagcaagctctacca
ccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaagaggattactccccagtctccaggcacgcgtca
gatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctggagaatcttggtgccgaagccgctcaattggt
cgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgccaagaggattactccccag
tctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgccctggagaatcttggtgcc
gaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcccccgcgttttaaccgcca
agaggattactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaactcgggatgcatcccgcc
ctggagaatcttggtgccgaagccgctcaattggtcgtagcaagctctaccaccgcttaaacgcacgtaagggctgtcc
cccgcgttttaaccgccaagaggattactccccagtctccaggcacgcgtcagatatatacatcctgtgcatgtattgaac
tcgggagatctgcatgcccgggc 
 
 
B 663 
 
tcagatgccgtatagcaaggatgcatgcaagcttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctc
acaattccacacaacatacgagccggaagcataaagtgtaaagcctggggtgcctaatgagtgagctaactcacatta
attgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagctgcattaatgaatcggccaacgcgcggg
gagaggcggtttgcgtattgggcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagc
29 
 
 
 
B 663 
cont. 
ggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagca
aaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacga
gcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccct
ggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtgg
cgctttctcatagctcacgctgtaggtatc 
B 540 
tcagcgatctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatct
ggccccagtgctgcaatgataccgcgagacccacgctcaccggctccagatttatcagcaataaaccagccagccgg
aagggccgagcgcagaagtggtcctgcaactttatccgcctccatccagtctattaattgttgccgggaagctagagtaa
gtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctcgtcgtttggtatggcttc
attcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcc
tccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgcc
atccgtaagatgcttttctgtgactggtgagtactcaaccaagtcattc 
B 426 
tgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccacatagcagaactt
taaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgt
aacccactcgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaa
aatgccgcaaaaaagggaataagggcgacacggaaatgttgaatactcatactcttcctttttcaatattattgaagcattt
atcagggttattgtctcatgagcggatacatatttgaatgtatttagaaaaataaacaaataggggttccgcgcacatttcc
ccgaaaagtgccacctgacgtc 
B 409 
tcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccg
gtaactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagca
gagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggt
atctgcgctctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggcaaacaaaccaccgctggta
gcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcctttgatcttttctacggg
gtctgacgc 
B 249 
tgagagtgcaccatatgcggtgtgaaataccgcacagatgcgtaaggagaaaataccgcatcaggcgccattcgcca
ttcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctattacgccagctggcgaaagggggatgtg
ctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagtgaattatgacg
acgcatacgatcac 
B 235 
taagaaaccattattatcatgacattaacctataaaaataggcgtatcacgaggccctttcgtctcgcgcgtttcggtgatg
acggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggatgccgggagcagaca
agcccgtcagggcgcgtcagcgggtgttggcgggtgtcggggctggcttaactatgcggcatcagagcagattgtac 
B 166 
tcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttttaaattaa
aaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcaccta
tc 
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Table 2.4: Native Gel Formulas 
5% Native Gel with Glycerol 
0.45 ml 20 x TTE 
3.75 ml 40% acrylamide/bis acrylamide29:1 
21.25 ml ddH2O 
3.75 ml 80% glycerol (v/v) 
0.30 ml 10% APS (w/v) 
0.03 ml TEMED 
5% Native Gel without Glycerol 
1.00 ml 10 x TBE 
3.75 ml 40% acrylamide/bis acrylamide29:1 
25.25 ml ddH2O 
0.30 ml 10% APS (w/v) 
0.03 ml TEMED 
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Figure 2.1: Chromatin Fractionation Procedure 
 
Schematic of the salt fractionation protocol. 
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Figure 2.2: In Vitro Nucleosome and Chromatin Constructs  
 
(a) The 247 bp DNA construct used in our FRET studies based on a modified 601 NPS 
and contains: a Cy3 fluorophore (position 43), a Gal4 binding site (position 58–76), and 
an extra 50 bp linker DNA at the 5’ (entry) and 3’ (exit) ends of the NPS. (b) 3055 bp 
DNA construct containing 17 NPSs in tandem separated by 30 bp linker DNA. (c) Each 
linker region has an AvaI digest site and the central NPS is modified to include a number 
of restriction enzyme digest sites. Numbers indicate positions of the restriction enzyme 
digest site with respect to the central NPS’s nucleosome boundary.  
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
Figure 2.3: Purification of Mononucleosomes 
 
(a) Fractions of 5-30% sucrose gradient used to purify excess nucleosomal DNA from 
reconstituted mononucleosomes. The fractions collected and pooled are indicated by 
black line. (b) After purification nucleosomes are heterogeneous (histone octamers 
centered and off-centered on the DNA). Heating nucleosomes at 55°C for 2 hours 
centers the nucleosome. Both gels are 5% native gels without glycerol and were stained 
post-run with GelStarTM Nucleic Acid Gel Stain (Lonza) and imaged on a Typhoon FLA 
9500 from GE Healthcare using the ECF filter. 
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Figure 2.4: Purification of Chromatin Arrays 
 
(a) Fully reconstituted chromatin arrays were purified from buffering DNA and free 
proteins via a 5-40% sucrose gradient (shown is a representative gel of fractions 
collected from the gradient). Line shows fractions that were pooled for subsequent 
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studies. (b) Gel showing DdeI digested 17mer plasmid and purified chromatin arrays 
after sucrose gradient purification. The chromatin arrays ran ~ 5 kb DNA marker band, 
while array DNA ran ~ 3 kb. Both gels are 0.7% Agarose gels and stained with GelStarTM 
Nucleic Acid Gel Stain (Lonza) and imaged on a Typhoon FLA 9500 from GE Healthcare 
using the ECF filter. (c) Schematic of AvaI digestion location and how nucleosome 
positioning changes digestion. (d) AvaI digests of purified remodeled chromatin arrays 
used to confirm correct placement and characterize the degree of saturation of the 
various chromatin arrays. Gels were stained post run with GelStarTM Nucleic Acid Gel 
Stain (Lonza) and imaged on a Typhoon FLA 9500 from GE Healthcare using the ECF 
filter. (e) Proteins precipitated from purified reconstituted arrays run on an 18% SDS-
polyacrylamide gel and stained with coomassie brilliant blue protein stain and imaged on 
an Odyssey® Infra-Red Imaging System (LI-COR). 
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Chapter 3: Inorganic Arsenic Changes Chromatin Structures and Gene Expression 
Patterns 
 
Introduction: 
 
iAs Exposure and Carcinogenesis 
Arsenic (As) is a ubiquitous metalloid that is a common environmental pollutant82-
84. Human exposure occurs mainly through contaminated drinking water85-88, especially 
in coal mining regions89, where the inorganic As (iAs) levels in the drinking water can 
exceed World Health Organization recommendations82,90. Long-term exposure to iAs is 
associated with the development of several diseases including coronary heart 
disease82,91,92, hypertension82,91,92, arteriosclerosis82,91,92, and liver93, bladder87,94,95, 
kidney96,97, and lung cancer85,98-101. As is found in several different oxidation states and 
its metabolism is integral to its disease causing potential. As5+ is sequentially reduced to 
As3+ followed by oxidative methylation to monomethylarsonic acid (MMA5+) and 
dimethylarsinic acid (DMA5+)102. These intermediates are reduced to trivalent arsenicals, 
MMA3+ and DMA3+, which act as potent cytotoxins and enzyme inhibitors which are 
important for iAs’s carcinogenic potential102. 
Although arsenic is a recognized human carcinogen, it is not mutagenic and 
therefore the mechanism(s) by which it causes cancer remain elusive103,104. Multiple 
studies have suggested that non-genotoxic modifications, such as altered gene and 
protein expression, DNA methylation, and epigenetic profiles, may be behind iAs-
mediated carcinogenesis 82,105-107. These studies suggest iAs targets diverse regulatory 
mechanisms, however, it remains to be determined if iAs influences mRNA splicing 
patterns, a key process in gene expression.  
Most studies have analyzed individual gene expression changes caused by the 
acute responses of cells to a high-dose iAs insult. Lacking are comprehensive studies on 
the global chromatin, transcriptome, and RNA splicing changes in response to low-dose, 
long-term iAs exposure. Equally important, and lacking, is an understanding of whether 
iAs induced gene expression changes are reversible, and to what extent, upon removal 
of the toxic insult. Such studies will have a fundamental impact on our understanding of 
how iAs affects human health, as they are more representative of how most humans are 
exposed to iAs.  
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Experimental Rational 
Accordingly, our lab set out to study the effects of chronic exposure to 
environmentally relevant doses iAs on these processes. Our work began by studying the 
effect of iAs on HeLa cells, which are routinely used to study cancer108. Key experiments 
were repeated in ‘normal’ BEAS-2B bronchial epithelial cells109, due to HeLa cells’ 
already carcinogenic nature and iAs’s association with lung and bronchial cancer 
development87,98,110,111. 
iAs in contaminated drinking water contains many subspecies of As, with As5+ 
and As3+ being the most prevalent84,88,91. However, it is the As3+ form that is associated 
with cancer development112-114. Accordingly, the cells were treated with 0.5 or 1 μM 
sodium arsenite (Na3AsO3)115 (fig 3.1), which has the cancer causing As3+ form and 
henceforth iAs will be used to indicate As with a 3+ valence. 
 
Lifespan, Morphology, and Global Gene Expression Pattern Changes in Response to 
iAs Exposure 
Work in our lab by Milie Ma found changes in growth rate, morphology, and 
lifespan in HeLa cells exposed to 1 µM iAs (iAs-T HeLa cells) and BEAS-2B cells treated 
with 0.5 µM iAs (iAs-T BEAS-2B cells). Both cell types showed a 2-phase response in 
growth rate after iAs exposure. During phase I (before 36 days for BEAS-2B and 45 
days for HeLa cells) iAs-T cells grow slower than non-treated (NT) cells; however, in 
phase II (after 36 days for BEAS-2B and 45 days for HeLa), iAs-T cells surpassed the 
growth rates of their NT counterparts115. Additionally, iAs-T HeLa cells become rounder, 
grow on top of each other, and lose their filapodia115. Furthermore, iAs-T BEAS-2B cells 
become more fibroblast-like and grow continuously without a detectable senescent 
phenotype115. Together these changes in growth rate, proliferation, and cell morphology 
suggest that these cells are going through the epithelial to mesenchymal transition 
(EMT), a hallmark of cancer progression116. The EMT was confirmed by western blot 
analysis for the known EMT markers vimentin117 and claudin-3115,118. Interestingly, the 
changes in EMT markers are dependent on the dose of iAs given to the cells115. 
Furthermore, removal of the iAs from the iAs-T HeLa cells for 10 days (iAs-Rev) partially 
returned cell morphology and EMT marker expression to its pre-exposure state115.  
Next, Millie Ma performed microarray analysis on the RNA from NT and iAs-T 
HeLa cells. iAs-T HeLa cells had the expression of many genes including ion and anion 
transporters and zinc finger-binding proteins changed115. Protein ANalysis THrough 
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Evolutionary Relationships (PANTHER)119 with gene ontology molecular function (GO 
MF) and gene ontology biological process (GO BP) analyses on the microarray results 
found that the genes most significantly affected in iAs-T HeLa cells are those involved in 
“cellular process regulation”(76 genes) and “metabolic process regulation” (85 genes)115. 
When the metabolic process class is divided into ‘primary’ (required for cell growth and 
survival) and ‘secondary’ (not required in cell survival), iAs mainly targets the primary 
metabolic processes115. Interestingly, Gene Set Enrichment Analysis (GSEA) shows that 
the expression of stress response genes, such as heat shock proteins, do not change in 
iAs-T cells, however some DNA repair proteins do115. 
 
Results:  
 
Global Gene Expression Patterns Change When iAs is Removed 
Since removal of iAs results in a partial return of cell morphology115 and iAs 
exposure changes gene expression genome wide115, we performed additional 
microarray analysis on RNA from NT, iAs-T, and iAs-Rev HeLa cells using the Affymetrix 
GeneChip® Human Transcriptome Array 2.0 system. 
We first set out to examine the differences in gene expression patterns from iAs-
T HeLa cells and iAs-Rev HeLa cells. Venn diagram analyses showed 26 differently 
expressed genes (DEGs) common between the two iAs exposure conditions (fig 3.2a), 
indicating that most genes that change due to iAs exposure reverted to their pre-
exposure levels after iAs was withdrawn for 10 days. Furthermore, comparison analysis 
of the DEGs between iAs-Rev HeLa cells and NT HeLa cells found that only 39 genes 
were differentially expressed (fig 3.2a). We theorize that because this set of genes did 
not revert back to NT levels they are involved in the progression of the defunct gene 
expression states seen in iAs-Rev HeLa cells. Like iAs-T HeLa cells115, ‘cellular and 
metabolic processes’ are the top-altered biological processes in both iAs-T and iAs-Rev 
cells (fig 3.2b).  
We next expanded our analysis of DEGs, as determined through microarray 
analysis, to include: NT vs iAs-T, NT vs iAs-Rev, and iAs-T vs iAs-Rev HeLa cells. Venn 
diagram analysis of the DEG shows genes that were permanently changed after iAs 
exposure in the overlapping region (fig 3.3a). Only seven DEGs were permanently 
changed: MFAP5 (microfibrillar associated protein 5), MGMT (O6-methylguanine DNA 
methyl transferase), miR3188 (microRNA 3188), CADM2 (cell adhesion molecule 2), 
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PLCL1 (phospholipase C-like 1), OPN3 (opsin 3), and PEX11A (peroxisomal biogenesis 
factor 11 alpha). Levels of MFAP5, which is associated with poor cancer prognosis120-122, 
were decreased in iAs-T HeLa cells compared to NT HeLa cells, while its expression 
was increased in iAs-Rev compared to iAs-T HeLa cells (fig 3.3b). However, its 
expression levels never returned to the levels observed in NT HeLa cells (fig 3.3b). 
MGMT, which is involved in the development of cancer123, CADM2, a tumor 
suppressor124, and PEX11A, a regulator of peroxisome proliferation125, expression levels 
ther have a mutation that affects their ability to interact with other co-regulatory 
PLCL1 expression levels were down-regulated in iAs-T HeLa cells and up-regulated in 
the iAs-Rev HeLa cells; interestingly, the expression of PLCL1 surpassed the levels in 
NT HeLa cells (fig 3.3b). Lastly, miR3188, which is important for posttranslational 
modifications in cancers126, and OPN3 expression levels were increased upon iAs 
exposure, and decreased when iAs was removed (fig 3.3b). 
We confirmed the microarray results using qRT-PCR (quantitative reverse 
transcription PCR) on 3 of the 7 genes whose expression was permanently altered in 
HeLa cells (fig 3.3c) and extended our qRT-PCR analysis to BEAS-2B cells (fig 3.3d). 
MGMT expression was down-regulated in both iAs-T HeLa cells (fig 3.3c) and iAs-T 
BEAS-2B cells (fig 3.3d) while OPN3 expression was up-regulated in iAs-T cells (fig 3.3c 
and 3.3d). In agreement with the partial return in morphology after iAs was removed115, 
MGMT expression was partially returned in iAs-Rev HeLa cells, and OPN3 expression 
was fully restored (fig 3.3c). Interestingly, there was a slight decrease in PEX11A 
expression in iAs-T HeLa cells and a further decrease in iAs-Rev HeLa cells (fig 3.3c) 
and a significant increase in PEX11A expression in iAs-T BEAS-2B cells (fig 3.3d). This 
indicates that iAs’ effect on cells can have both universal and cell-specific targets.  
 
iAs Exposure Mediates Alternative Splicing of Specific Genes 
Organisms use alternative splicing to increase their transcriptome diversity127, 
which can help cope with environmental stress128. Therefore, we next asked if iAs 
exposure affects alternative splicing using the Affymetrix GeneChip® Human 
Transcriptome Array 2.0 microarray system, which can measure alternative splicing 
events129. Interestingly, iAs-T HeLa cells had only 104 genes there were both 
alternatively spliced and differently expressed compared to NT HeLa cells (table 3.1). 
This indicates that iAs does not impact the general splicing mechanism but is specific for 
a subset of genes. Furthermore, ~75% of these alternative splicing events occurred in 
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genes with decreased expression in iAs-T HeLa cells (fig 3.4a). We confirmed that the 
change in splicing patterns was not a side effect of the change in gene expression level 
through semi-quantitative RT-PCR using primers designed to distinguish between 
splicing variants (table 2.1). Semi-quantitative RT-PCR was performed on two down-
regulated genes, MGP1 (matrix gla protein 1) and NCAM2 (neural cell adhesion 
molecule 2), and one up-regulated gene ABCG2 (ATP-binding cassette sub-family G 
member 2). In addition to the general increase of ABCG2, iAs exposure caused more 
ABCG2 isoforms to be expressed (fig 3.4b). NT HeLa cells only expressed isoform c (fig 
3.4b); after iAs treatment, however, cells expressed three isoforms a, b, and c (fig 3.4b). 
Both NT and iAs-T HeLa cells expressed both isoforms e and f, but after iAs treatment 
the ratio of the isoforms changed (fig 3.4b). NT BEAS-2B cells expressed isoform a and 
isoform c (fig 3.4b).  Upon iAs treatment 2 additional isoforms, b and d, were expressed 
(fig 3.4b). Like the HeLa cells, both NT and iAs-T BEAS-2B cells expressed isoforms e 
and f, however after exposure to iAs the relative expression of these isoforms changed 
(fig 3.4b). NT and iAs-T HeLa cells only expressed isoform a of MGP1, with iAs-T cells 
expressing less (fig 3.4c). Interestingly, once iAs was withdrawn HeLa cells began to 
express isoform b (fig 3.4c). Furthermore, iAs-T BEAS-2B cells also expressed isoform b 
(fig 3.4c). The most dramatic results were seen in the alternative splicing profile of 
NCAM2 (fig 3.4d). NT HeLa cells had an isoform pattern distinct from both iAs-T and 
iAs-Rev HeLa cells (fig 3.4d). Similarity, NT BEAS-2B cells had an isoform pattern 
distinct from iAs-T BEAS-2B cells (fig 3.4d). In both cells types only 2-3 isoforms were 
expressed in all conditions (fig 3.4d). Furthermore, some isoforms present were not 
predicted in the Ensembl genome browser release 75; therefore, these results are 
currently being further examined within the lab. Interestingly, only ABCG2’s isoform 
expression profile was returned in iAs-Rev HeLa cells (fig 3.4b). Thus, a majority of 
genes have three distinct expression profiles: before iAs exposure, during iAs exposure, 
and post iAs exposure.  
Exposure to iAs causes HeLa and BEAS-2B cells to undergo EMT115, have 
widespread changes in their gene expression115 and gene splicing patterns (fig 3.4). 
However, iAs in non-mutagenic82, therefore, we hypothesized that there are underlying 
chromatin structure and/or an epigenetic mechanism driving the EMT. 
 
Exposure to Low Doses of iAs Changes Nucleosome Spacing 
Since the nucleosome repeat length (NRL) is key to chromatin structure5 and 
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genome wide transcriptional profiles13,69,130, we used micrococcal nuclease (MNase) 
digestion to measure the NRL in NT, iAs-T, and iAs-Rev cells.  
Chromatin from HeLa and BEAS-2B cells was digested in situ with MNase to 
generate nucleosome ladders that were resolved by agarose gel electrophoresis (fig 
3.5). iAs-T BEAS-2B cells had an increase in NRL of ~4 bp (fig 3.5a). Interestingly, the 
increase in the NRL of HeLa cells was dose dependent as treatment with 0.5 M iAs (0.5 
iAs-T) resulted in an ~5 bp increase in NRL and treatment with 1 M iAs increased the 
NRL by ~9 bp (fig 3.5b). These changes in NRL corresponded to the morphological 
changes previously observed115. Furthermore, the NRL decreased by ~3 bp in iAs-Rev 
cells compared to iAs-T HeLa cells, thus bringing the NRL closer to that of the NT HeLa 
cells (fig 3.5b). The increased NRL suggest that exposure to iAs results in chromatin 
with less periodicity and reduced average nucleosomal spacing, which is indicative of 
the more compact heterochromatin115. We confirmed this proposed increase in 
chromatin compaction by showing that chromatin from iAs-T cells was more resistant to 
stringent digest by MNase compared to NT cells (fig 3.6). The changes in nucleosomal 
spacing and MNase accessibility suggest that iAs exposure results in 
heterochromatinization.  
 
Chromatin’s Protein Content Changes in Response to iAs Treatment Exposure 
In addition to the NRL, chromatin structural changes can be represented by 
changes in its protein content. Specifically, changes in the chromatin architectural 
protein (CAP) content may indicate a different higher order chromatin structure51,131,132. 
In addition to the increased NRL (fig 3.5), iAs-T cells had a ~30% increase in the 
repressive CAP histone H1’s protein levels (Manana Melikishvili, personal 
communication). Therefore, we next tested, by salt fractionation of chromatin, whether 
iAs exposure changed CAP-chromatin association patterns. Salt fractionation of 
chromatin uses the charge buffering capabilities of NaCl to measure the stability of the 
interactions of proteins to chromatin, which rely on non-sequence, charge based 
interactions (fig 2.1). 
If the iAs treatment is affecting chromatin organization, iAs-T cells are expected 
to have different protein/chromatin association patterns. Therefore, we examined the 
CAPs associated with the chromatin of NT, 0.5 iAs-T, and iAs-T HeLa cells. iAs 
treatment induced a dose-dependent increase in insoluble chromatin as represented by 
the increase in relative amount of DNA in the 600 mM NaCl and pellet chromatin 
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fractions (fig 3.7a). Furthermore, iAs treatment resulted in changes in the amount of the 
CAPs HMGN1 (high mobility group protein-1) and histone H1; however, it did not change 
the chromatin fractions with which they associated (fig 3.7b). For instance, histone H1 
levels increased globally, yet it remained strongly associated with the insoluble 600 mM 
NaCl and pellet chromatin fractions (fig 3.7b). Moreover, the activating CAP HMGN1, 
while globally down-regulated, remained present in the soluble chromatin fraction 
regardless of iAs exposure status (fig 3.7b). Interestingly, there was an iAs-dose-
dependent increase in PARP-1’s (poly-ADP-ribose polymerase) association with the 
more soluble chromatin fractions and an increase in cleaved PARP-1 (fig 3.7b), a 
hallmark of apoptosis133. We posit that iAs is selectively interacting with PARP-1’s zinc 
finger domains134, resulting in PARP-1 being released from DNA, making it more soluble. 
These changes in chromatin solubility and protein content of chromatin further suggest 
that there is an increase in heterochromatinization in iAs-T HeLa cells. 
 
Discussion: 
 
iAs is a well-established carcinogen that induces a number of diseases including 
several cancers82,98,135. However, the molecular mechanisms mediating iAs 
carcinogenicity and disease pathology are not completely understood. Our findings 
demonstrate that the adaptive changes in BEAS-2B and HeLa cells due to iAs exposure 
include changes in gene expression115, alternative splicing patterns (fig 3.4), and the 
chromatin structure (figs 3.5, 3.6, and 3.7). Furthermore, withdrawal of iAs results in the 
partial restoration of some, but not all, gene expression patterns (figs 3.2, 3.3, and 3.4) 
and chromatin structures (figs 3.5, 3.6, and 3.7). Thus, the disease etiology associated 
with iAs exposure could be linked to both the initial effects of iAs exposure and/or the 
permanent alteration of some gene expression patterns. Additionally, most of these 
patterns were consistent in both HeLa and BEAS-2B cells, suggesting some iAs-
mediated pathways might be universal. 
 We showed that in both the normal bronchial epithelial BEAS-2B cells and the 
cervical cancer HeLa cells iAs treatment led to increased NRL (fig 3.5), decreased 
MNase accessibility (fig 3.6), increased chromatin-bound histone H1 (fig 3.7), and 
decreased chromatin-bound HMGN1 (fig 3.7), all indicating heterochromatinization. 
These changes in chromatin structure correlate with alterations in gene and microRNA 
(miRNA) expression115 and alternative splicing patterns (fig 3.4). Furthermore, removal 
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of iAs showed a remarkable partial reversal of many gene expression patterns (figs 3.2, 
3.3, and 3.4) and chromatin structures (figs 3.5, 3.6, and 3.7). However, some key 
genes/miRNA expression remain altered after the iAs is removed (Pex11A fig 3.3 and 
MGP1 and NCAM2 fig 3.4). Together these data indicate that altered gene expression is 
a consequence of chronic iAs exposure and suggests that iAs alters several methods of 
gene expression regulation including changes in chromatin structure, gene and miRNA 
expression levels, and mRNA splicing patterns. 
We showed that specific changes in gene and miRNA expression and splicing 
patterns accompany iAs withdrawal (figs 3.2, 3.3, and 3.4). This suggests that constant 
insult from iAs is not necessary for its carcinogenic affects, as there are three distinct 
expression profiles (before, during, and after iAs exposure) and therefore gene 
expression patterns remain altered even when iAs insult is discontinued (figs 3.2, 3.3, 
and 3.4). Moreover, it is possible that the change in specific miRNA expression is a 
mechanism through which iAs regulates protein levels, for example miR124-1 targets 
Slug to regulate EMT and metastasis136, and the overexpression of miR200b is 
implicated in the reversal and prevention of iAs induced malignant transformation in lung 
cells137. This is particularly interesting since four out of the seven significantly altered 
miRNAs (miR101-1, miR1-1, miR1185-1, miR1266, miR31, miR4637, and miR4779) 
target genes important in cancer pathways, thus implicating the deregulation of these 
miRNAs in iAs induced carcinogenesis.  
Furthermore, our bulk chromatin analyses suggest an increase in 
heterochromatinization upon exposure to iAs (figs 3.5, 3.6, and 3.7) and a reduction in 
heterochromatinization upon the withdrawal of iAs (figs 3.5 and 3.6). Further supporting 
the proposed heterochromatinization in response to iAs exposure, is the up-regulation of 
DOT1L, the only known H3K79me3 methyltransferase in iAs-T cells138. These results are 
in accordance with previous studies reporting that iAs induces an increase in repressive 
histone marks and a decrease in activating marks113. Additionally, recent epidemiological 
studies confirm that iAs significantly changes, in a dose-responsive manner, the 
epigenetic marks at the promoters of oncogenes113,139, and changes nucleosome 
occupancy at several iAs target genes115. Together with our work these studies hint at a 
potential epigenetic mechanism by which iAs alters chromatin structure to regulate gene 
expression patterns.  
Overall, our comprehensive genome-wide study provides new insights into 
markers and mediators of iAs responses within the cell. Such detailed and 
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comprehensive studies are important in dissecting the causes and effects of iAs 
exposure in order to determine its gene regulatory mechanisms.  
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Table 3.1: Genes Alternatively Spliced in iAs-T HeLa Cells 
Down-regulated and Spliced 
UCA1 MFAP5 ARHGDIB MGP 
CD36 LPL SAGE1 UST 
GJB5 SLC43A3 NCAM2 COL5A2 
AKT3 ITPR1 GNAT3 CYP4F22 
ITGB4 PLAUR KCTD12 SCN9A 
COL15A1 LGALS3BP SEMA6A NPAS2 
EDNRA L1CAM ETV4 MRPL17 
SEMA4B ALOX15B RNF122 FRMD3 
HLA-DMA LINGO2 ALS2CR8 SDC2 
TTLL1 SIDT1 RIBC2 COL25A1 
SASH1 ARL6IP6 ISM2 IDH2 
SUSD4 C16orf58 STAT5A DIRA3 
ANK2 CPM LUZP2 DOTL1L 
PLXND1 RPS6KA2 TSPAN18 SHC4 
ELANE MDGA2 KCNV1 CDY2B 
HLA-F PTH1R FHL2 P2RX4 
GATA4 IFT140 KLHL31 SHC3 
UQCRC1 NUDT8 CDH5 NPFFR2 
SLITRK4 PDZD4 MKX FCER1G 
PTK6 PRKCG SEC22C NAT6 
NEGR1-IT1 
Up-regulated and Spliced 
DOK2 THAP3 PDCD6 NOSTRIN 
PRR23A PYCARD GZMH STEAP2 
T1CAM1 SLC45A4 COL24A1 C1S 
FAM212B RYR2 LIMD1 SQSTM1 
ZNF469 FABP3 TRIM16 ZNF323 
DHRS2 UGAT1A5 SEMA3A ALDH3A1 
SH3GL2 ABCG2 HMOX1 
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Figure 3.1: iAs Treatment Conditions 
 
Diagram of iAs treatment conditions and naming system. 
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Figure 3.2: Analyses of Common Genes and Their Biological Function between NT 
and iAs-T/iAs-Rev HeLa Cells 
 
(a) Venn diagram showing the genes common between the two conditions. (b) 100% 
stacked column analysis to visualize biological functions, as determined by PANTHER, 
GO MF, and GO BP analyses, of differently expressed genes in iAs-T and iAs-Rev HeLa 
cells.  
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Figure 3.3: Analyses of Common Genes and Their Change in Expression Level of 
NT, iAs-T, and iAs-Rev HeLa Cells 
 
(a) Venn diagram of genes common to the various conditions. (b) Heat map of gene 
expression changes from microarray data on NT vs iAs-T and NT vs iAs-Rev HeLa cells. 
The analysis shows relative fluorescence from green (down-regulated) to red (up-
regulated) of the six genes and one microRNA found common in the experimental 
conditions. qRT-PCR analysis of total RNA from (c) HeLa and (d) BEAS-2B cells of 
select genes relative to NT cells, to validate the changes in mRNA expression 
microarray data. Results from three experiments were plotted ± standard deviation and a 
student’s t-test was used to determine significance* (p<0.05). 
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Figure 3.4: Splicing-Sensitive Microarray Analysis and Validation 
 
(a) Distribution of genes that change in gene expression and alternative splicing in iAs-T 
HeLa cells (compared to NT HeLa cells). Representative gels of RT-PCR analysis of 
iAs-mediated alternative splicing events are shown for (b) ABCG2, (c) MGP1, and (d) 
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NCAM2. Primer locations for each RT-PCR assay are shown by arrows. Agarose gels 
were stained using GelStarTM Nucleic Acid Gel Stain (Lonza) and imaged on a Typhoon 
FLA 9500 from GE Healthcare using the ECF filter. Band intensities were quantified 
using ImageQuantTL. 
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Figure 3.5: iAs Treatment Causes a Reduction in Nucleosome Spacing 
 
Nuclei from (a) NT and iAs-T BEAS-2B cells and (b) NT, 0.5 iAs-T, iAs-T, and iAs-Rev 
HeLa cells were digested with MNase and the bulk chromatin was analyzed by agarose 
gel electrophoresis stained with ethidium bromide and imaged on a Gel Doc™ by Bio-
Rad. The NRL was calculated by plotting data from 3 independent experiments ± 
standard deviation of the nucleosome number versus DNA length compared to known 
DNA ladders.  
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Figure 3.6: iAs Treatment Resulted in Cells with More Compact Chromatin 
 
MNase digested chromatin, under increasingly stringent conditions, was run on an 
agarose gel stained with ethidium bromide and imaged on a Gel Doc™ by Bio-Rad.  
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Figure 3.7: DNA and Protein Characterization of Chromatin from HeLa Cells 
with/without Arsenic Treatment 
 
Equal volumes of the MNase extraction, 80/150/600 mM NaCl extractions, and the 
remaining pellet (as indicated in fig 2.1) were run on an (a) ethidium bromide-stained 
agarose gel (imaged on a Gel Doc™ by Bio-Rad) and a (b) 4-12% SDS-polyacrylamide 
gel followed by western blot analysis for chromatin architectural proteins and other 
chromatin associated proteins to probe the DNA and protein content (respectively) of 
each fraction. 
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Adapted and reprinted in full or part with permission from:  
Inorganic Arsenic-Induced Cellular Transformation is Coupled with Genome-Wide 
Changes in Chromatin Structure, Transcriptome and Splicing patterns. BMC 
Genomics. 2015;16(1). Caitlyn Riedmann1, Millie Ma1, Manana Melikishvili, S. 
Grason Godfrey, Zhou Zhang, Eric Rouchka, Kuey Chu Chen, and Yvonne N. 
Fondufe-Mittendorf. 1Authors contributed equally  
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Chapter 4: Chromatin Architectural Proteins Stabilize Higher Order Chromatin 
Structures 
 
Introduction: 
 
Chromatin Architectural Proteins in Transcriptional Regulation 
Chromatin architectural proteins (CAPs) are linked to specific transcriptional 
outcomes60,130,140,141, and, as shown in chapter 3, can respond to different environmental 
factors. These distinct transcriptional outcomes are essential for maintaining cellular 
homeostasis69,142-144. Therefore, CAP expression levels are tightly controlled and CAP 
ratios, relative to both other CAPs and nucleosomes, have cell- and tissue-type 
specificity that are susceptible to changes depending on developmental 
stage13,26,65,145,146. For example, during early development in higher eukaryotes, high 
mobility group N1 (HMGN1) is highly expressed, allowing for rapid replication and 
transcription of genes130. As development progresses, histone H1 expression increases 
and HMGN1 levels decrease resulting in functional, specialized chromatin domains 
necessary for cell type-specific gene expression49,69,130,147. Furthermore, mature neurons 
express the CAPs linker histone H1 and methyl CpG binding protein 2 (MeCP2) at a 
unique 1:1 ratio26. This is due to both the high expression of MeCP2 in mature neurons 
and the reduction in histone H1 expression by half26. If there is a loss of function 
mutation in MeCP2 the histone H1 levels do not decrease26. Consequently, the mature 
neurons of patients with Rett Syndrome (RTT), who have a loss of function mutation in 
MeCP2, can also be distinguished by their altered expression levels of histone H1, and 
the corresponding change in ratio between histone H1/MeCP2, coupled with widespread 
transcriptional deregulation26,143. 
 
Chromatin Architectural Proteins in Higher Order Chromatin Structure 
The transcriptional regulation provided by CAPs is linked with the higher order 
structures they help create/maintain65,141,148,149. When no CAPs are present, in vitro 
nucleosomes within a chromatin array do not wrap in a uniform conformation, even 
under salt concentrations which favor chromatin wrapping25,145. Without this uniformity, 
the higher order structure is unable to tightly wrap around itself, a process critical for the 
creation of the organized higher chromatin structures necessary for genomic 
compaction6. Most work on CAPs, and their relationship to higher order structures, have 
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focused on the repressive CAP histone H1 and the neural CAP MeCP2. Even in 
substoichiometric concentrations the presence of either histone H1 or MeCP2 is able to 
provide enough of a framework for the individual nucleosomes within the array for a 
higher ordered structure to develop25,145. This higher structure becomes more stable, 
uniform, and compact with increasing amounts of histone H1 or MeCP225,145.  
Interestingly, while the ratio of a particular CAP to nucleosome within the cell 
does not tend to equal 1:1, the ratio of total CAPs to nucleosome is maintained at this or 
higher ratios26,51,130. This suggests that not only repressive CAPs, like histone H1 and, 
potentially, MeCP2, have a role in higher order stability, but activating CAPs, like the 
HMG family, do as well. However, there have been a lack of studies on how activating 
CAPs alter the stability of higher chromatin structures. Therefore, we set out to 
determine the effect of histone H1, MeCP2, and high mobility group D1 (HMGD1), a 
Drosophila HMGN1 homolog on chromatin higher order structure and stability. 
 
In Vitro Accessibility Assay 
We created a 17 nucleosome higher order chromatin structure by reconstituting 
histone octamers and CAPs with a 3 kilobase (kb) DNA array template containing 17 
‘601’ nucleosome positioning sequences (NPSs) separated by 30 base pairs (bp) of 
linker DNA (fig 2.2b)11,79,150. The 601 NPS is the 147 base pairs of DNA with the highest 
affinity for nucleosome binding76. The central NPS within the array has been modified to 
include multiple restriction enzyme digest sites (fig 2.2c). The ability of a restriction 
enzyme (RE) to bind and digest its target site is dependent on if the DNA is actively 
wrapped around a histone octamer. Accordingly, it is only when the DNA is dissociated 
from the octamer that RE digestion will occur151,152. DNA target site accessibility was 
measured by comparing the band intensity of the full-length array DNA (3 kb) to the 
cleavage product (1.5 kb), which is about half the length of the full array.  
Since the REs used require Mg2+ as a cofactor, all chromatin arrays were 
digested in conditions containing 1 mM Mg2+, which is important to note, as this Mg2+ 
concentration causes in vitro nucleosomal arrays to undergo a reversible compaction 
resembling the compaction of native chromatin fibers in vivo153. However, since this ionic 
environment is the same in all experiments, any observed change in digestion would be 
caused by a difference in chromatin structure induced by CAP binding.  
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Results: 
 
Breathing vs. Stability in Higher Order Chromatin Structures 
We tested for the accessibility of two restriction enzymes whose cleavage site is 
in different locations within the central NPS: BamHI (position 49) and PstI (position 5) (fig 
2.2c). Due to its location at the center of a NPS site, digestion by BamHI is a sign of 
overall higher order structure instability as ~ 1/3 of the DNA must unwrap from the 
histone octamer for digestion to be possible. The PstI digestion site, on the entry DNA of 
the histone octamer, is a better representation of a transcription factor binding site in 
vivo154-156. 
First, we digested the arrays with 40 U of BamHI as a measure of higher order 
structure stability (fig 4.1a). Since this is a measure of stability we compared the amount 
of BamHI digestion in arrays remodeled by ISWI (fig 4.1b lanes 2, 4, 6, and 8). After 
remodeling, the chromatin arrays bound by CAPs were significantly less digested than 
the chromatin array not bound by CAPs (fig 4.1c, table 4.1). These results suggest that 
CAPs facilitate chromatin remodeling by ISWI, which extends the previous observation 
that ISWI regulates the higher-order chromatin structure by promoting the assembly of 
histone H1-containing chromatin38,39. Thus suggesting, that in addition to facilitating the 
formation of higher order structures, CAPs increase the stability of these structures. 
Next, we exposed the arrays to 5 U PstI, a measure of TF accessibility (fig 4.2a). 
Remodeling the arrays with ISWI resulted in a significant decrease in digestion in all 
arrays (fig 4.2b compare lanes: 1 and 2, 3 and 4, 5 and 6, and 7 and 8, table 4.2). 
However the difference in digestion after remodeling was doubled in the CAP containing 
chromatin arrays (fig 4.2c and table 4.2). This lends further support for the interaction 
between CAPs and ATP-dependent chromatin remodelers for creating appropriate 
higher order chromatin structures. We did not observe any significant differences in PstI 
digestion among the ISWI remodeled CAP containing chromatin arrays (fig 4.2b lanes 2, 
4, 6, and 8, table 4.2). However, there was a significantly higher amount of digestion in 
No CAP chromatin arrays compared to every CAP stabilized chromatin array tested (fig 
4.2c, table 4.2). Thus, in addition to providing overall chromatin stability, CAPs affect the 
accessibility of DNA target sites wrapped within the chromatin structure. 
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CAP Stoichiometry in In Vitro Chromatin Arrays 
Globally CAPs are present in a >1:1 stoichiometric ratio to nucleosomes26,130,146. 
However, it is known that they bind in a cooperative fashion to chromatin24,157 and they 
compete with each other for nucleosome binding24,44,130. Thus, differences in the local 
concentration of CAPs could result in different higher structures in vivo. Therefore, we 
set out to characterize the stability of higher chromatin structures with CAPs in excess to 
nucleosomes. Since we were interested in how excess CAPs change the stability of 
chromatin arrays we digested the arrays with BamHI (position 49 of the central NPS, fig 
4.3a). Additionally, to determine if there were nuanced differences in digestion not 
observable with high amounts of BamHI, the arrays were digested with multiple 
concentrations of BamHI. Furthermore, since CAPs in excess to nucleosomes require 
more binding sites, AvaI digestion could generate a nucleosome ladder, even if the 
octamers are centered. Therefore, no remodeling reaction or AvaI digest was performed 
on the arrays with the increased number of CAPs. 
Unlike when CAPs were added in an equal amount to histone octamers (23 
CAPs: 23 histone octamers: 1 array DNA), arrays with excess CAPs (300 CAPs: 23 
histone octamers: 1 array DNA) had distinct digestion patterns (fig 4.3b). Interestingly, 
the BamHI digestion pattern of HMGD1-bound chromatin arrays did not differ from the 
array not stabilized by CAP (fig 4.3c). Furthermore, while the digestion pattern of arrays 
bound by MeCP2 and histone H1 did not significantly differ from each other (fig 4.3c). 
However, both MeCP2- and histone H1-chromatin arrays provided significantly more 
protection from digestion compared to No CAP- and HMGD1-chromatin arrays (fig 4.3c). 
Thus, the CAPs with repressive capabilities generated more stable higher order 
structures, while the activating CAPs generated a structure with a stability similar to no 
CAP.  
 
Susceptibility to Salt Concentration 
Changes in Mg2+ concentration are known to have a dramatic influence on the 
higher order compaction of in vitro chromatin structures without CAPs151,158. Since CAPs 
also help dictate what higher order structure chromatin takes we set out to determine if 
CAPs change the susceptibility of arrays to BamHI digestion in a different Mg2+ 
concentration. Accordingly, BamHI digestions were performed on chromatin arrays with 
CAPs in excess to nucleosomes (300 CAPs: 23 histone octamers: 1 array DNA). As 
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described above the arrays were not remodeled with ISWI, and were digested with 
increasing amounts of BamHI in a buffer with 10 mM Mg2+.  
In the 10 mM Mg2+ environment, each CAP facilitated distinct BamHI digestion 
patterns (fig 4.4b). In agreement with figure 4.1, chromatin arrays not stabilized by CAP 
provided the least protection from digestion (fig 4.4d). Chromatin stabilized by the 
activating CAP HMGD1 had the most accessible digest site out of the arrays bound by 
CAPs (fig 4.4d). Interestingly, chromatin arrays bound by MeCP2 were digested less 
than arrays bound by the known repressive CAP histone H1 (fig 4.4d). This is in line with 
the in vivo data that found that MeCP2 represses long non-tandem repeats and long 
genes better than histone H126,66. Thus, together with the results from figure 4.3, 
supporting the role of repressive CAPs creating/maintaining higher order structures that 
are more stable that those arrays stabilized by activating CAPs. 
 
Discussion: 
 
Taken together we conclude that the CAPs histone H1, MeCP2, and HMGD1 
stabilize higher order chromatin structures (figs 4.1, 4.3, and 4.4). Furthermore, these 
CAPs respond to different environmental conditions including CAP concentration (fig 
4.3) and salt environment (fig 4.4) with distinct effects. Additionally, we show that all 
three CAPs studied work with the ATP-dependent chromatin remodeler ISWI to create 
and stabilize these higher order chromatin structures (figs 4.1 and 4.2). Thus expanding 
previous results which show that SWI/SNF remodeling favors nucleosomes on end 
positions when no histone H1 is present to favoring centrally positioned nucleosomes 
with histone H140. In contrast, a recent study showed that HMGB1 (a human HMG family 
protein)43,159 increased the rate of repositioning by the ISWI ATPase complex based on 
its ATP-utilizing chromatin assembly and remodeling factor (ACF) and chromatin 
accessibility complex (CHRAC), but did not change the resulting octamer location154. 
Taken together, these observations suggest that CAPs might regulate transcription by 
differentially modulating chromatin remodeling.  
In these studies, we determined the effect of histone H1, MeCP2, and HMGD1 
on chromatin structures in vitro. Using these simplified in vitro models we can shed light 
on the in vivo alterations in chromatin structure produced by CAPs and provide a way to 
ascertain DNA accessibility. Such studies contribute critical information for 
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understanding the epigenetic roles played by CAPs and how CAPs respond to changes 
in the local environment. 
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Table 4.1: Percent of Array DNA Uncut Following Digestion with 40 U BamHI for 1 
Hour  
Chromatin 
Array 
% Uncut 
% Changed 
- ISWI + ISWI 
No CAP 69.50 ± 8.43 62.05 ± 4.12 -7.45 ± 4.12 
Histone H1 87.07 ± 3.32 88.10 ± 1.98 1.03 ± 1.98 
MeCP2 89.27 ± 9.85 85.27 ± 2.87 -4.00 ± 2.87 
HMGD1 79.53 ± 5.98 88.94 ± 2.61 9.41 ± 2.61 
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Table 4.2: Percent of Array DNA Uncut Following Digestion with 5 U PstI for 15 
Minutes 
Chromatin 
Array 
% Uncut 
% Changed 
- ISWI + ISWI 
No CAP 23.47 ± 2.06 40.11 ± 1.59 16.64 ± 1.59
Histone H1 19.12 ± 1.42 54.34 ± 8.98 35.22 ± 8.98
MeCP2 19.72 ± 3.41 50.02 ± 1.37 30.30 ± 1.37
HMGD1 16.76 ± 0.68 57.93 ± 7.18 41.14 ± 7.18
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Figure 4.1: CAPs Stabilize Higher Order Chromatin Structures 
 
Remodeled (+ISWI) and non-remodeled (-ISWI) chromatin samples were digested with 
BamHI, whose digestion site is 49 base pairs into the central NPS (a). The resulting 
DNA was deproteinized and run on an agarose gel stained with GelStarTM Nucleic Acid 
Gel Stain (Lonza) and imaged on a Typhoon FLA 9500 from GE Healthcare using the 
ECF filter. ImageQuantTL imaging software was used to measure the intensity of the full 
and digested array DNA after remodeling with ISWI. (c) These values were used to 
determine the percent uncut. Error bars are the mean  standard deviation of triplicate 
experiments and a student’s t-test was used to determine significance* (p<0.05). 
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Figure 4.2: CAP-Mediated Higher Order Chromatin Structures are Susceptible to 
Chromatin Remodeling by ISWI 
 
Remodeled (+ISWI) and non-remodeled (-ISWI) chromatin samples were digested with 
PstI, which digests 5 base pairs into the central NPS (a). (b) The arrays were 
deproteinized and run on an agarose gel stained with GelStarTM Nucleic Acid Gel Stain 
(Lonza) and imaged on a Typhoon FLA 9500 from GE Healthcare using the ECF filter. 
ImageQuantTL imaging software was used to measure the intensity of the full and 
digested array DNA. (c) These values were used to determine the percent uncut. Error 
bars are the mean  standard deviation of triplicate experiments and a student’s t-test 
was used to determine significance* (p<0.05). 
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Figure 4.3: CAPs in Excess of Nucleosomes Distinguish Accessibility of DNA in 
Arrays Stabilized by Repressive and Activating CAPs 
 
Chromatin samples were digested with increasing amounts of BamHI which digests at 
position 49 of the central NPS (a). (b) The resulting array was deproteinized and the 
DNA run on an agarose gel stained with GelStarTM Nucleic Acid Gel Stain (Lonza) and 
imaged on a Typhoon FLA 9500 from GE Healthcare using the ECF filter.  ImageQuantTL 
imaging software was used to measure the intensity of the full and digested array DNA. 
(c) These values were used to determine the percent uncut, and fit to a one phase 
exponential decay plot. Error bars are the mean  standard deviation of triplicate 
experiments and a student’s t-test was used to determine significance* (p<0.05). 
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Figure 4.4: BamHI Digestion in 10 mM Mg2+ Distinguish Accessibility in 
Chromatosome-Specific Higher Order Arrays 
 
(a) Chromatin samples were digested with increasing amounts of BamHI, which digests 
at position 49 of the central NPS (a), in the presence of 10 mM Mg2+. (b)The resulting 
array was deproteinized and run on an agarose gel stained with ethidium bromide and 
imaged on a Gel Doc™ by Bio-Rad. ImageQuantTL imaging software was used to 
measure the intensity of the full and digested array DNA. These values  standard 
deviation of triplicate experiments were used to determine the percent uncut and fit to a 
one phase exponential decay plot (c) and (d). A student’s t-test was used to determine 
significance* (p<0.05). 
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Adapted and reprinted in full or part with permission from:  
Comparative Analysis of Linker Histone H1, MeCP2, and HMGD1 on Nucleosome 
Stability and Target Site Accessibility. Scientific Reports. 2016; 6. Caitlyn 
Riedmann and Yvonne N. Fondufe-Mittendorf. 
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Chapter 5: Chromatin Architectural Proteins Change Mononucleosome Dynamics 
 
Introduction: 
 
Nucleosomes and Cis-Site Occlusion 
Chromatin is composed of repeating nucleosomes, which are formed when 147 
base pairs (bp) of DNA wrap around a histone octamer core7. By wrapping into 
nucleosomes, DNA target sites become physically contorted and/or sterically occluded 
from their binding proteins10,12,160-163. The nucleosomes are connected with linker DNA 
which can range from 23 base pairs (nucleosome repeat length [NRL] = 170 base pairs) 
to 71 base pairs (NRL = 218 base pairs)13.  The length of linker DNA changes depending 
on environmental conditions115, tissue type13, and stage of development13,69,164. Thus, 67-
86% of genomic DNA is actively wrapped around the core histone octamer, and 
accordingly, cis acting sites are hidden within nucleosomes. Nucleosome positions 
throughout the genome are not random155,165-168. Factors such as DNA sequence and 
epigenetic modifications work together so that relevant cis-acting sites are found in the 
accessible linker region and the entry/exit DNA of the nucleosome155,165-168. Even 
accounting for this strategic placement of nucleosomes167,169, key cis-acting sits will be 
occluded from their binding proteins throughout the genome. Therefore, there must be a 
mechanism within the cell for these sites to become accessible for binding.  
 
‘Nucleosome Breathing’ Theory 
‘Nucleosome breathing’, the spontaneous and transient dissociation of DNA from 
the histone octamer, provides a mechanism for the DNA target sites to become 
intermittently accessible to their binding proteins10,12,160-163. The stability of the charge-
based non-sequence-specific interaction of nucleosomes is highly susceptible to salt 
concentration changes within its environment10,12. While the effect of factors such as 
histone post-translational modifications (PTMs) on nucleosome breathing have been 
extensively studied10,145,147,170-173, the effect of chromatin architectural proteins (CAPs) on 
nucleosome breathing has remained generally unexplored. Since CAPs bind the 
entry/exit DNA and the nucleosome dyad51,140,145 to form chromatosomes, we 
hypothesize that chromatosomes have different rates of nucleosome breathing, which 
adds another level of regulation on essential biological functions. 
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In Vitro Breathing Assay 
 We used a Cy3-Cy5 paired Förster Resonance Energy Transfer (FRET) 
mononucleosome system to measure the differences in chromatosome formation and 
breathing. The Cy3 labeled DNA is based on the ‘601’ nucleosome positioning sequence 
(NPS), which has the highest affinity for nucleosome binding76. The modified 601 NPS 
includes a Gal4 binding site and 50 bp of entry and 50 bp of exit linker DNA (fig 2.2a)81. 
This DNA is wrapped around a histone octamer that is labeled with Cy5 on both copies 
of H2A K119C81. Since FRET efficiency is a measure of the distance between the Cy3 
label on the DNA to the Cy5 label on the histone octamer and the Förster distance of the 
Cy3-Cy5 pair is 5.6 nm174, changes in FRET efficiency can be attributed to the 
wrapping/unwrapping of the DNA from the octamer core10,12. Thus, the FRET efficiency 
of the spontaneously breathing nucleosome will increase if the nucleosome is stabilized 
with the DNA wrapped around the octamer, or decrease if the dissociated nucleosome 
conformation is stabilized10. This Cy3-Cy5 nucleosome system is sensitive enough that 
simply changing the salt concentration by as little as 40 mM is enough to have a 
measureable change in FRET efficiency10. Therefore all experiments were performed in 
the physiologically relevant 130 mM NaCl175. Furthermore, like the higher order 
chromatin structures, nucleosomes are dynamic and using the NPS does not guarantee 
the centering of the octamer on the DNA after storage176. Accordingly, before CAPs/Gal4 
were added to the binding reaction, the nucleosomes were heated at 55°C for 2 hours. 
This causes the nucleosomes to move to the most thermodynamically favored position, 
which is when the histone octamer is centered on the NPS (fig 2.3b)78. Thus, all binding 
studies were performed on a homogeneous nucleosome population. 
 
Results: 
 
Chromatosome Formation 
Since CAPs bind nucleosomes through different mechanisms41-43, compete for 
binding24,51, and change the transcriptional landscape of regions of chromatin26,51, we set 
out to determine the unique binding properties of our model CAPs including nucleosome 
affinity, changes in nucleosome conformation, and changes in DNA target site 
accessibility. We first examined each CAP’s affinity for binding mononucleosomes, or 
chromatosome formation, through electromobility gel shift analysis (EMSA)177. In order to 
monitor the affinity of chromatosome formation using a pseudo-first order binding 
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reaction, increasing amounts of CAP (1-250 nM) were titrated into a consistent and low 
concentration (5 nM) of mononucleosomes. The CAPs and nucleosomes were incubated 
on ice for 3 min to reach equilibrium (unpublished result) and the resulting complexes 
were resolved on a 5% native acrylamide gel with glycerol (table 2.4). The three model 
CAPs exhibited differences in the concentration-dependent shifts (fig 5.1). Drosophila 
histone H1 caused a shift between 10-15 nM, with a further shift occurring at 50 nM (fig 
5.1a), however, the complexes formed when 75 nM or more of histone H1 was added 
were too large to be resolved by the native polyacrylamide gel (fig 5.1a). Concentrations 
between 25-50 nM of human MeCP2 shifted the nucleosomes, with a super shift 
occurring at higher concentrations (75-250 nM) of MeCP2 (fig 5.1b). A Drosophila 
HMGD1 concentration between 1-5 nM caused a gel shift, with further shifts occurring in 
a laddering pattern, consistent with previous studies on HMGD1-chromatosome 
formation178, beginning at 10 nM HMGD1 (fig 5.1c). Overall, these results demonstrate 
that under our experimental conditions, all three CAPs bind nucleosomes with distinct 
profiles and affinities. 
 
Histone H1 and MeCP2 Regulate Breathing Dynamics 
Since CAPs bind to the entry/exit DNA of the nucleosome45,179 and change the 
higher order chromatin structures131,145, we hypothesize that CAP binding stabilizes 
either an open or closed nucleosome conformation. Accordingly, we predict that 
repressive chromatosomes will trap the nucleosome in a wrapped conformation leading 
to an increase in the FRET efficiency, while activating chromatosomes will either have 
no effect on nucleosome breathing, resulting in no change in FRET efficiency, or will 
stabilize the opening of the nucleosome resulting in a decrease in FRET efficiency. As in 
our EMSA studies (fig 5.1), we used a pseudo-first order binding reaction by titrating 
CAPs (1-250 nM) into 5 nM Cy3-Cy5 FRET paired mononucleosomes. These reactions 
were incubated for ~5 minutes at room temperature before FRET measurements were 
taken. The non-normalized FRET spectra (panel a of figs 5.2-5.4 and 5.6-5.11) were 
used to calculate the FRET efficiency (panel b of figs 5.2-5.4 and 5.6-5.11). However, for 
ease of trend visualization, FRET spectra from select concentrations were normalized to 
Cy3 emission and plotted (panel c of figs 5.2-5.4 and 5.6-5.11). 
As predicted by our hypothesis and studies on human histone H1 isoforms81, 
chromatosomes formed with Drosophila histone H1 had an increase in FRET efficiency 
(fig 5.2b), evidence of a stabilized closed nucleosome conformation. Similarly, MeCP2-
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chromatosomes had an increased in FRET efficiency (fig 5.3b), suggesting that MeCP2 
also traps the nucleosome in a wrapped conformation. In contrast, HMGD1-
chromatosomes had a FRET signature similar to the spontaneously breathing 
nucleosomes (fig 5.4a). This could indicate that either: 1) HMGD1 binding has no impact 
on nucleosome breathing dynamics, or 2) since these are ensemble FRET studies, the 
HMGD1-chromatosomes facilitate a nucleosome conformation that has a FRET 
signature similar to that of the spontaneously breathing nucleosome. Further studies will 
need to be done in order to distinguish between these two possibilities. 
Because chromatosomes are stabilized through charge based interactions41,45, 
we next examined how chromatosomes changed breathing dynamics in a 0 nM NaCl 
environment. Interestingly, the general CAP trends did not change. Both histone H1 and 
MeCP2 formed chromatosomes with increased FRET efficiency (fig 5.6 and 5.7) while 
HMGD1 chromatosomes had a FRET profile similar to the spontaneously breathing 
nucleosomes (fig 5.8). However, when the reactions were performed in 0.5 x TE, instead 
of the standard Nuc Buffer 130, more CAP was needed to bring about a change in FRET 
efficiency. Thus, while the effect of chromatosome formation is independent of the NaCl 
environment, its affinity of formation is not. 
Next, we fit the FRET efficiency values to a Hill binding curve in order to calculate 
the S1/2 value, which is the concentration of CAP needed to bring half of the total change 
in FRET efficiency. Since both histone H1- and MeCP2-chromatosome formation 
changes the FRET efficiency (figs 5.2, 5.3, 5.6, and 5.7), the S1/2 value can be used as a 
measure of chromatosome formation. However, due to the lack of measurable change in 
FRET efficiency upon HMGD1-chromatosome assembly (figs 5.4 and 5.8), only the data 
for histone H1 and MeCP2 chromatosome formation was analyzed (fig 5.5). 
Furthermore, the higher CAP concentrations needed to change the FRET efficiency 
when the reactions were performed in 0.5 x TE resulted in no top trend line for histone 
H1 and MeCP2 aggregation as evident in the decreasing FRET (fig 5.7b, 300 nM). 
Therefore, these FRET efficiency values could not be fit to a Hill binding curve to 
determine their affinity for chromatosome formation (fig 5.5c). In the experiments 
performed in 130 mM NaCl, 12.09  2.08 nM histone H1 is required to trap the 
nucleosome in a wrapped conformation compared to 20.73  4.98 nM MeCP2 (fig 5.5a 
and table 5.1). Excitingly, these values correspond with the range of concentrations of 
histone H1 (15 nM) and MeCP2 (25 nM) needed to bring about a noticeable gel shift (fig 
5.1a and 5.1b). Since both histone H1 and MeCP2 are known to bind cooperatively to 
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longer chromatin arrays5,24,180, we also fit the FRET efficiency measurements to a Hill 
binding curve with a Hill coefficient, a measure of binding cooperativity (fig 5.5b). This 
did not change the affinity measurement, and interestingly, both CAPs have a similar 
degree of cooperativity (histone H1 = 1.55  0.38, MeCP2 = 1.59  0.46) (table 5.1). 
Furthermore, Drosophila histone H1 chromatosomes had a higher FRET efficiency 
compared to MeCP2 chromatosomes (fig 5.5a), indicating that histone H1 is able to 
stabilize a more tightly wrapped nucleosome structure than the structure stabilized by 
MeCP2. These results suggest that the model repressive CAP histone H1 forms more 
compacted chromatosomes with a higher affinity than the neural CAP MeCP2.  
 
Chromatosomes Change Nucleosomal DNA Accessibility 
Finally, we determined whether the differences in chromatosome breathing 
dynamics affected DNA target site accessibility. Since most genomic DNA is wrapped 
into nucleosomes166 the ability of DNA binding proteins to access their target sites is a 
key factor in every DNA-templated event. To examine changes in the accessibility of 
DNA target sites wrapped around nucleosomes we used the yeast transcription factor 
Gal4’s binding site that was incorporated into the Cy3 labeled mononucleosome 
construct. This target sequence is located at positions 8–26 of the 601 NPS (fig 2.2a) as 
this is demonstrative of transcription start site placement throughout the genome154-156. 
The binding of Gal4 1-147 to its cis binding site traps the nucleosome in a partially 
unwrapped state and sterically prevents nucleosome rewrapping, thereby leading to a 
decrease in FRET efficiency181,182. We confirmed that the binding of Gal4’s DNA binding 
domain (Gal4 1-147), a kind gift from the Poirier Lab at The Ohio State University, to the 
DNA in our mononucleosomal construct reduces FRET efficiency by titrating 0.1-300 nM 
of Gal4 1-147 into 5 nM of mononucleosomes (fig 5.9). Based on our hypothesis, 
repressive chromatosomes will limit the spontaneous breathing of the nucleosome, 
thereby hindering Gal4 1-147 from binding its target site. This will result in a higher 
concentration of Gal4 1-147 required to decrease the FRET efficiency in repressive 
chromatosomes compared to spontaneously breathing nucleosomes. We tested Gal4 1-
147 binding in a dynamic environment by exposing nucleosomes to 15 nM Drosophila 
histone H1 or 25 nM human MeCP2, their respective S1/2 (table 5.1) and first observable 
gel shift (figs 5.1a and 5.1b) values, before Gal4 1-147 was added (figs 5.10 and 5.11). 
As in our nucleosome breathing studies and in accordance with published protocols81, 
we fit the FRET efficiency values to a Hill binding curve with a Hill coefficient, however 
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we normalized the FRET efficiency values from 1 (0 nM Gal4 1-147) to 0 (300 nM Gal4 
1-147) in order to directly compare how chromatosome formation changes Gal4 1-147’s 
ability to bind its target site. Since the binding curve is dependent on the Gal4 1-147 
concentration, the S1/2 value indicates the amount of Gal4 1-147 needed to bind its 
cognate site and open the nucleosome (fig 5.12 and table 5.2). When Gal4 1-147 was 
titrated into a population of spontaneously breathing nucleosomes (No CAP), the S1/2 
value was 3.06  0.14 nM Gal4 1-147(table 5.2). Consistent with our hypothesis, when 
Gal4 1-147 was titrated into the histone H1-chromatosomes the S1/2 value increased 
more than 4-fold to 12.75  4.6 nM (table 5.2). Similarly, MeCP2-chromatosomes 
required 12.16  1.34 nM of Gal4 1-147 to drive the opening of the nucleosome (table 
5.2). These results demonstrate that by trapping the nucleosome in a wrapped state 
both histone H1 and MeCP2 inhibit Gal4 1-147 from binding to its target site. 
Furthermore, even in the presence of histone H1 and MeCP2, Gal4 is still able to bind its 
target site via DNA unwrapping81, suggesting that repressive CAPs can regulate 
transcription factor binding by suppressing the probability of target site exposure when 
the nucleosome is partially unwrapped. Interestingly, MeCP2 limited Gal4 1-147 binding 
to a similar extent as histone H1 (fig 5.12). Thus, even though histone H1 forms more 
compact chromatosomes with a higher affinity (figs 5.5a and 5.5b), once MeCP2-
chromatosomes are formed they are as efficient as histone H1-chromatosomes at 
blocking DNA target site binding (fig 5.12 and table 5.2). 
 
Discussion: 
 
Multiple studies have compared the nucleosome binding profiles of histone H1 
and MeCP224 or histone H1 and HMGD151. However, this is the first comparative 
analysis of histone H1, MeCP2, and HMGD1 on chromatosome formation (fig 5.1), 
chromatosome breathing (fig 5.5), and nucleosomal DNA accessibility (fig 5.12). 
Moreover, this is the second study to use the Cy3-Cy5 paired mononucleosome FRET 
system to compare multiple CAPs. However, the first study compared multiple human 
histone H1 isoforms81, thus our work is the first to use this system to compare CAPs with 
such vastly different transcriptional profiles26,51,60,183. Furthermore, these studies 
demonstrate that the binding of these three CAPs facilitate differences in 
mononucleosome breathing (fig 5.5) and DNA target site accessibility profiles (fig 5.12) 
that imply their downstream effect on transcription. Our studies clearly show that both 
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Drosophila histone H1 and human MeCP2 trap the mononucleosome in a compact state 
(fig 5.5) and reduce target site accessibility (fig 5.12). We also demonstrate that HMGD1 
binding does not affect ensemble FRET efficiency (figs 5.4 and 5.8).  
The most exciting aspect of these results is the similarity of histone H1- and 
MeCP2-chromatosomes at preventing Gal4 1-147 from binding its target site (fig 5.12). 
The nucleosomes in these studies are epigenetically neutral, meaning no histone post 
translational modifications nor DNA methylation. Yet MeCP2 is named for its affinity for 
binding methylated DNA25,61,184. It is possible that MeCP2-chromaotosomes made with 
methylated DNA will have increased affinity for formation and, potentially, will be better 
than histone H1-chroamtosomes at limiting DNA target site accessibility, making it an 
even more potent repressor. However, future studies are needed to verify this idea.  
This FRET system provides a way to de-couple chromatosome formation (fig 5.5) 
from the CAP’s effect on DNA target site accessibility (fig 5.12). This feature will be 
particularly important for understanding Rett Syndrome causing MeCP2 mutations, 
which are most frequently located in its methyl binding domain (chromatosome 
formation) and its transcriptional repression domain (DNA target site accessibility). 
However, we must remember that in vivo, the interplay of CAPs with other epigenetic 
factors is required for robust chromatin changes in DNA accessibility. 
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Table 5.1: S1/2 Values for the Binding of CAPs to Cy3-Cy5 Paired 
Mononucleosomes 
CAP S1/2 (nM) 
Hill 
Coefficient 
Histone H1 12.09 ± 2.08 1.55 ± 0.38 
MeCP2 20.73 ± 4.98 1.59 ± 0.46 
HMGD1 N / A N / A 
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Table 5.2: S1/2 Values of Gal4 Binding to Nucleosomes Not Stabilized by CAP, 
Stabilized by 15 nM Histone H1, or Stabilized by 25 nM MeCP2 
Chromatosome S1/2  
(nM Gal4) 
Hill 
Coefficient 
No CAP 3.06 ± 0.14 3.76 ± 2.16 
15 nM Histone H1 12.75 ± 4.60 1.18 ± 0.48 
25 nM MeCP2 12.16 ± 1.34 1.47 ± 0.22 
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Figure 5.1: Chromatosome Formation is Unique to Each CAP 
 
CAP-chromatosomes were created by titrating 0-250 nM of (a) Drosophila histone H1, 
(b) human MeCP2, or (c) Drosophila HMGD1 into 5 nM nucleosomes. Once binding 
equilibrium was reached, samples were run on a 5% native acrylamide gel with glycerol 
to view CAP-chromatosome formation. Gels were stained post-run with GelStarTM 
Nucleic Acid Gel Stain (Lonza) and imaged on a Typhoon FLA 9500 from GE Healthcare 
using the ECF filter. 
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Figure 5.2: Histone H1 Forms Chromatosomes that Increase FRET Efficiency 
 
Drosophila histone H1 was titrated into 5 nM Cy3-Cy5 paired FRET mononucleosomes 
to measure changes in nucleosome breathing dynamics due to CAP binding. (a) Histone 
H1-chromatosomes were excited with 510 nm light and the emission spectrum collected 
from 550–750 nm. (b) FRET efficiency was calculated from the spectra using the RatioA 
method and select concentrations were plotted. Error bars for all graphs are the 
standard deviation of two replicates. A student’s t-test was used to determine 
significance* (p<0.05). (c) To visualize the change in Cy5 emission due to the change in 
nucleosome conformation the spectra graphs from the selected concentrations were 
normalized to their Cy3 emission. 
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Figure 5.3: MeCP2 Forms Chromatosomes with Increased FRET Efficiency 
 
Human MeCP2 was titrated into 5 nM Cy3-Cy5 paired FRET mononucleosomes to 
measure changes in nucleosome breathing dynamics due to CAP binding. (a) MeCP2-
chromatosomes were excited with 510 nm light and the emission spectrum collected 
from 550–750 nm. (b) FRET efficiency was calculated from the spectra using the RatioA 
method and select concentrations were plotted. Error bars for all graphs are the 
standard deviation of two replicates. A student’s t-test was used to determine 
significance* (p<0.05). (c) To visualize the change in Cy5 emission due to the change in 
nucleosome conformation the spectra graphs from the selected concentrations were 
normalized to their Cy3 emission. 
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Figure 5.4: HMGD1-Chromatosomes Do Not Change FRET Efficiency 
 
Drosophila HMGD1 was titrated into 5 nM Cy3-Cy5 paired FRET mononucleosomes to 
measure changes in nucleosome breathing dynamics due to CAP binding. (a) HMGD1-
chromatosomes were excited with 510 nm light and the emission spectrum collected 
from 550–750 nm. (b) FRET efficiency was calculated from the spectra using the RatioA 
method and select concentrations were plotted. Error bars for all graphs are the 
standard deviation of two replicates. A student’s t-test was used to test for significance. 
(c) To visualize the change in Cy5 emission due to the change in nucleosome 
conformation the spectra graphs from the selected concentrations were normalized to 
their Cy3 emission. 
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Figure 5.5: CAPs Form Chromatosomes with Distinct FRET Signatures 
 
The FRET efficiency measurements ± standard deviation were plotted on a semi-log 
graph based on CAP concentration. Chromatosomes formed in the presence of 130 mM 
NaCl were fit to a Hill binding curve (a) without and (b) with the Hill coefficient, a 
measure of cooperativity. Due to the lack of measurable change in FRET efficiency upon 
HMGD1 binding, no Hill curve was fit. (c) FRET efficiency measurements cannot be 
drawn for chromatosomes formed in a no NaCl environment due to no top trend line for 
histone H1-chromatosomes, aggregation of MeCP2-chromatosoems, and no change in 
FRET efficiency of HMGD1-chromatosomes.  
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Figure 5.6: Histone H1-Chromatosomes Increase FRET Efficiency in a No NaCl 
Environment 
 
Drosophila histone H1 was titrated into 5 nM Cy3-Cy5 paired FRET mononucleosomes 
in an environment without NaCl to measure how changes in NaCl concentration affected 
histone H1-chromataosome conformation. (a) Histone H1-chromatosomes were excited 
with 510 nm light and the emission spectrum collected from 550–750 nm. (b) FRET 
efficiency was calculated from the spectra using the RatioA method and select 
concentrations were plotted. Error bars for all graphs are the standard deviation of three 
replicates. A student's t-test was used to determine significance* (p<0.05). (c) To 
visualize the change in Cy5 emission due to the change in nucleosome conformation the 
spectra graphs from the selected concentrations were normalized to their Cy3 emission. 
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Figure 5.7: MeCP2-Chromatosomes Increase FRET Efficiency in a No NaCl 
Environment 
 
Human MeCP2 was titrated into 5 nM Cy3-Cy5 paired FRET mononucleosomes in an 
environment without NaCl to measure how changes in NaCl concentration affected 
MeCP2-chromataosome conformation. (a) MeCP2-chromatosomes were excited with 
510 nm light and the emission spectrum collected from 550–750 nm. (b) FRET efficiency 
was calculated from the spectra using the RatioA method and select concentrations were 
plotted. Error bars for all graphs are the standard deviation of three replicates. A 
student's t-test was used to determine significance* (p<0.05). (c) To visualize the change 
in Cy5 emission due to the change in nucleosome conformation the spectra graphs from 
the selected concentrations were normalized to their Cy3 emission. 
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Figure 5.8: HMGD1-Chromatosomes Do Not Change FRET Efficiency in a No NaCl 
Environment 
 
Drosophila HMGD1 was titrated into 5 nM Cy3-Cy5 paired FRET mononucleosomes in 
an environment without NaCl to measure how changes in NaCl concentration affected 
HMGD1-chromataosome conformation. (a) HMGD1-chromatosomes were excited with 
510 nm light and the emission spectrum collected from 550–750 nm. (b) FRET efficiency 
was calculated from the spectra using the RatioA method and select concentrations were 
plotted. Error bars for all graphs are the standard deviation of three replicates. A 
student's t-test was used to determine significance* (p<0.05). (c) To visualize the change 
in Cy5 emission due to the change in nucleosome conformation the spectra graphs from 
the selected concentrations were normalized to their Cy3 emission. 
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Figure 5.9: Gal4 1-147 Binds its Target Site and Decreases FRET Efficiency 
 
Gal4 1-147 was titrated into 5 nM Cy3-Cy5 paired mononucleosomes. After equilibrium 
the nucleosomes were exposed to 510 nm light and (a) the emission spectra collected 
from 550-750 nm. (b) FRET efficiency was calculated from the spectra using the RatioA 
method and select concentrations were plotted. Error bars for all graphs are the 
standard deviation of four replicates. A student's t-test was used to determine 
significance* (p<0.05). (c) To visualize the change in Cy5 emission due to the change in 
nucleosome conformation the spectra graphs from the selected concentrations were 
normalized to their Cy3 emission. 
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Figure 5.10: Gal4 1-147 Binds its Target Site within Histone H1-Chromatosomes 
and Decreases FRET Efficiency 
 
Cy3-Cy5 paired mononucleosomes were exposed to 15 nM Drosophila histone H1 (its 
S1/2 value, table 5.1) before Gal4 1-147 was titrated into the system. The resulting 
complexes were exposed to 510 nm light and (a) the emission spectra collected from 
550-750 nm. (b) FRET efficiency was calculated from the spectra using the RatioA 
method and select concentrations were plotted. Error bars for all graphs are the 
standard deviation of two replicates. A student's t-test was used to determine 
significance* (p<0.05). (c) To visualize the change in Cy5 emission due to the change in 
nucleosome conformation the spectra graphs from the selected concentrations were 
normalized to their Cy3 emission. 
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Figure 5.11: Gal4 1-147 Binds its Target Site within MeCP2-Chromatosomes and 
Decreases FRET Efficiency 
 
Cy3-Cy5 paired mononucleosomes were exposed to 25 nM human MeCP2 (its S1/2 
value, table 5.1) before Gal4 1-147 was titrated into the system. The resulting complexes 
were exposed to 510 nm light and (a) the emission spectra collected from 550-750 nm. 
(b) FRET efficiency was calculated from the spectra using the RatioA method and select 
concentrations were plotted. Error bars for all graphs are the standard deviation of three 
replicates. A student's t-test was used to determine significance* (p<0.05). (c) To 
visualize the change in Cy5 emission due to the change in nucleosome conformation the 
spectra graphs from the selected concentrations were normalized to their Cy3 emission. 
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Figure 5.12: Histone H1- and MeCP2-Chromatosomes Hinder Gal4 1-147 from 
Binding its Target Site within Mononucleosomes 
 
The FRET efficiency values ± standard deviation were plotted on a semi-log graph 
based on Gal4 1-147 concentration, and fit to a Hill binding curve with a Hill coefficient 
since Gal4 1-147 binds cooperatively. 
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Adapted and reprinted in full or part with permission from:  
Comparative Analysis of Linker Histone H1, MeCP2, and HMGD1 on Nucleosome 
Stability and Target Site Accessibility. Scientific Reports. 2016; 6. Caitlyn 
Riedmann and Yvonne N. Fondufe-Mittendorf. 
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Chapter 6: Conclusions and Future Directions 
 
Integration of In Vivo and In Vitro Research 
 Given the interplay between chromatin structure and many epigenetic marks 
(e.g. DNA methylation and the histone code), determining direct causal relationships 
between them, other binding proteins, and transcription is quite difficult. Genome-wide 
studies provide insight into what chromatin structures and epigenetic marks are 
connected to transcriptional profiles and binding patterns. Unfortunately, these studies 
are descriptive and are therefore limited to correlation. In vitro biophysical and 
biochemical studies are much more direct as they remove the compensatory 
mechanism(s) of the cell. Thus, while these in vitro studies are better at determining 
causation, they are limited to the specific questions the researcher asks. In this study, 
we have used both general approaches to study two distinct questions: 1) how does 
long-term exposure to low-dose iAs affect transcription through the regulation of 
chromatin structure and 2) how do chromatin architectural proteins (CAPs) regulate the 
structural dynamics and DNA accessibility within nucleosomes and chromatin. However, 
it is when these two general approaches are combined that we can see their 
experimental power. By using the in vivo work to guide in vitro studies we can get a 
more robust and complete understanding of epigenetic regulation. 
 One challenge in determining the molecular mechanisms directing epigenetic 
regulation is due to the fact that multiple epigenetic marks are located on top of each 
other. Since in vitro biophysical methods can incorporate different nucleosome repeat 
lengths (NRLs), DNA methylation, DNA hydroxymethylation, DNA hemimethylation, and 
different histone post translational modifications (PTMs) in many different patterns, they 
can help tease apart how the many epigenetic signals work together. For example, 
MeCP2 is associated with H3K9me2/H3K27me3 nucleosomes185. This association could 
be because: 1) H3K27me3 recruits H3K9me2, which in turn binds MeCP2, therefore 
making MeCP2 independent of H3K27me3, 2) MeCP2 binds H3K27me3 and then 
recruits H3K9me2, making MeCP2 the linchpin of the multiple marks, or 3) MeCP2 may 
only bind when both H3K27me3 and H3K9me2 are together. This complexity is not 
limited to MeCP2, as histone H1 (isoform H1.2 specifically) is found with H3K7me3 186 
and H3K56ac81 and HMGD1 is associated with H4K16ac51. Nor is this complexity limited 
to CAPs and the histone code, as DNA methylation status is also associated with 
multiple epigenetic profiles31. Distinguishing these possibilities from each other will be 
92 
 
much simpler in an in vitro setting, since they can be manipulated individually and the 
results will be independent of any compensatory mechanism within the cell. 
 While our work to date has not combined these approaches, it has shown how 
each approach can address specific questions in chromatin biology. Furthermore, it has 
validated the use of these biophysical methods to compare multiple CAPs in the same 
epigenetic environment. The power of combining in vivo and in vitro methods has long 
been established as a powerful tool in understanding complex cellular processes. 
However, recent advancements in in vitro techniques and the epigenetic marks these 
techniques can incorporate makes the combination of in vivo and in vitro techniques a 
powerful upcoming approach in understanding multiple aspects of epigenetic research. 
 
Chromatin Structural Changes in Response to iAs 
The molecular mechanism and the downstream genes that mediate inorganic 
arsenic’s (iAs, 3+ valence) carcinogenicity have yet to be understood. To date, several 
studies have been carried out to determine the pathways and genes involved in the 
adaptive responses cells undergo upon exposure to high doses of iAs leading to its 
toxicity and pathogenesis82. However, studies on the gene alterations, both 
transcriptionally and post-transcriptionally, have been lacking and are necessary to 
understand iAs mediated cellular adaptation and disease progression. Accordingly, we 
have carried out a systematic and comprehensive study to determine the chromatin 
structural and gene expression profile changes elicited by iAs exposure. Our results 
show that there are clear systemic changes in the genomic organization of cells exposed 
to iAs are linked with the epithelial to mesenchymal transition (EMT) progression. 
Interestingly, some, but not all of these structural and epigenetic modifications, are 
identical in multiple cell types. Thus, our work has exposed general iAs mediated 
changes and diverse cell specific adaptations to iAs exposure. Additionally, changes to 
the underlying chromatin structures are integral to both the shared and unique adaptive 
responses. Furthermore, these adaptive changes occurred in response to both the 
addition and removal of iAs, showing that these changes are a direct response to iAs.  
 Changes in chromatin organization can have widespread effects on cellular 
function18,70,187,188. Accordingly, iAs exposure led to an increase in heterochromatin, the 
tightly condensed form of chromatin. By increasing the NRL (fig 3.5) and changing the 
underlying chromatin organization, iAs exposure alters what transcription start sites and 
other cis acting sites are located in the accessible linker regions of the chromatin. 
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Furthermore, the increase in chromatin bound histone H1 and corresponding decrease 
in HMGN1 (fig 3.7) suggests that iAs changes the ability of the cell to access the cis 
acting sites that are activity wrapped into the nucleosome (chapter 5). Accordingly, iAs 
changes the gene expression profiles of both the normal epithelial BEAS-2B and cervical 
cancer HeLa cells115. These altered expression profiles favor the expression of genes 
that drive cell division, which is not surprising given iAs carcinogenic nature and the fact 
that iAs exposure causes both cell types to progress through EMT115. Interestingly, these 
changes not only affected transcript levels of genes and miRNAs115, but it also changed 
the splicing patterns of a specific subset of genes (fig 3.4 and table 3.1). Since 
alternative splicing is a mechanism the cell uses to increase its genetic diversity127 it acts 
as another level of gene regulation. Therefore, these altered splicing patters are just as 
key to iAs’ carcinogenic behavior as the altered transcript levels.  While carcinogenic is 
usually used interchangeably with mutagenic, cancer development is dependent on 
aberrant transcription, not mutations specifically. Thus, these chromatin structural and 
epigenetic profile changes in response to iAs provide a mechanism for iAs mediated 
carcinogenesis while accounting for iAs non-mutagenic properties102-104. 
 There are widespread changes to chromatin and epigenetic signatures not only 
in response to the addition of iAs, but also to its removal. This is intriguing given the 
mobile nature of humans, who could have periods of higher iAs exposure followed by 
permanent, or temporary, removal of the iAs insult. After iAs is removed, the NRL 
decreases (fig 3.5) and some gene transcript/miRNA levels (figs 3.2 and 3.3) and 
isoform expression patterns (fig 3.4) return to their pre-exposure state. However, not all 
profiles returned. The NRL remained higher than its never exposed counterpart (fig 3.5), 
some gene/miRNA transcript levels were permanently altered (fig 3.3), and some novel 
alternative splicing isoforms appeared (fig 3.4). Thus, once a cell is exposed to iAs it will 
not return to pre-exposure chromatin or transcriptional profiles. Not surprisingly, iAs 
removal brings about antagonistic changes to the chromatin structure compared to iAs 
exposure, resulting in increased euchromatin (fig 3.5) and decreased EMT markers115. 
Therefore, removal of iAs could be both harmful and beneficial for the development of 
cancer. While EMT is essential for cancer to become metastatic, the reverse process, 
mesenchymal to epithelial transition (MET), is necessary for the establishment of 
secondary tumors189. Thus, if an organism is exposed to iAs long enough for EMT to 
make the cancerous cells fully mobile the subsequent removal could drive the MET of 
these cells in multiple tissues leading to tumor propagation. 
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 Overall, our genome-wide study provides new insights into markers and 
mediators of cellular adaptation to iAs exposure. Such detailed and comprehensive 
studies are important in dissecting the cause and effect of iAs exposure on chromatin 
structures and their consequences on gene regulatory mechanisms. While iAs is 
involved in carcinogenesis, it is also used in the treatment of acute promyelocytic 
leukemia (APL)190,191. Thus, it is possible that the anti-carcinogenic and carcinogenic 
actions of iAs share a common molecular mechanism that is related to level of iAs 
exposure (high dose vs. low dose), length of exposure (chronic vs. acute), and/or 
species of As the organism is exposed (e.g. arsenite, arsenate, etc.). Thus, it will be 
important to ask whether epigenetic changes also mediate As based cancer therapy. 
Our studies provide a platform to begin defining these epigenetic changes. 
 
CAP Regulation of Chromatin Structure and Transcription 
 It is becoming increasingly clear that chromatin architectural proteins (CAPs) not 
only provide scaffolding for specific higher order chromatin structures, but are also 
integral for the proper regulation of many biological processes. During early 
development in higher eukaryotes, HMG1 is the main CAP, allowing for rapid replication 
and transcription of genes130. As development progresses, histone H1 expression 
increases resulting in functional, specialized chromatin domains necessary for cell type-
specific gene expression69. While most cells and organisms have between 0.5 and 1 
histone H1 protein per nucleosome192, the number of individual CAPs differ among cell 
type and developmental stage69,192,193. Thus, since CAPs are just starting to get their 
proper recognition within the relatively young field of epigenetics, it is a very exciting time 
for this work. In our study, we demonstrate that the neural CAP MeCP2, the repressive 
CAP Drosophila histone H1, and the activating CAP Drosophila HMGD1 are necessary 
to stabilize higher order chromatin structures (fig 4.1) and that each CAP has an unique 
binding profile (fig 5.1). 
 Histone H1 is by far the most studied and best understood CAP, this is not 
surprising given histone H1’s abundance throughout model organisms69 and tissue 
types194,195. The linker histone H1 has many known isoforms including H1.0, H1.1, H1.2, 
H1.3, H1.4 and H1.5 in humans194,196, histone H5 in chickens197, and the various 
evolutionarily conserved histone H1 proteins throughout higher eukaryotes196. In mice, 
the histone H1 isoforms H1a, H1b, H1c, H1d, and H1e 69, are functionally redundant as 
long as the collective amount of histone H1 maintains the critical mass necessary for 
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genome-wide regulation69. However histone H5, the linker histone in birds and fish179, 
histone H10, a mouse isoform69, and histone H1.0 in humans, are known to repress 
transcription better than the other histone H1 isoforms179,197. Thus, redundancy does not 
mean equality. While experimental barriers have limited our understanding of these 
various forms of linker histone in the past, technical advancements are breaking these 
barriers and comparisons of the proteins can be made. For instance, in vitro studies 
found that histone H1.0 has a higher affinity for unmodified nucleosomes compared to 
K122ac nucleosomes81, however it limited transcription factor binding similarly on both 
nucleosomes81. These advancements are not limited to in vitro techniques as 
advancements in gene editing, especially thanks to CRISPR/Cas9, is making the study 
of individual isoforms possible in vivo, which has been previously impossible due to 
viability issues in model organisms69.  
 Activating CAPs are as important in maintaining cellular function. Fittingly, the 
HMG family of activating CAPs has multiple isoforms which have been evolutionarily 
conserved in higher eukaryotes146,159,183,198,199. Given the disorder of chromatin arrays 
without CAPs145, our results suggest that activating CAPs provide the structural stability 
needed for organized compaction (fig 4.1) without forming a barrier to active 
transcription (fig 5.4 and 5.8). However, we recognize that the relationship between 
CAPs and transcription is not that simple. For example, in histone H1 knockdown cells 
HMGD1 occupies previously histone H1-bound promoters without increasing gene 
expression51. However, in HMGD1 knockdown cells, histone H1 binds promoters 
previously bound by HMGD1 and gene expression decreases51. Furthermore, MeCP2 
has been shown to both activate71,200 and repress26,63 transcription genome wide. 
Therefore, we hypothesize that in vivo the interaction between CAPs and epigenetic 
factors can influence the downstream consequences, either by reducing or enhancing 
the CAP’s affect. This further demonstrates the benefits of in vitro methods which can 
provide insight into the interplay of these multiple factors. 
One of the most exciting aspects of CAP research is the study of CAPs in other 
gene expression processes, particularly alternative splicing. Multiple CAPs have been 
directly linked to changes in alternative splicing187,201. Yet this potential avenue of CAP 
mediated regulation has remained virtually unexplored. Since CAPs are predicted to 
assemble a distinct higher-order chromatin structure, genomic chromatin will not be 
structurally homogeneous, but rather, partitioned into many different micro-domains 
dictated by the specific protein composition of the region in question. Thus, the presence 
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of CAPs may be essential in providing the functional specialization of chromatin domains 
within different cell-types and lineages. We predict that these functional domains have 
distinct and specific expression and splicing profiles. 
 
MeCP2 as a Transcriptional Regulator 
 Within mature neurons MeCP2 is expressed at a level equal to histone H126 and 
is required to maintain cellular integrity143,202-204. Loss of function mutations in MeCP2 
cause widespread transcriptional changes35,71,142,148 that lead to Rett Syndrome 
(RTT)54,202,205-208. However, the transcriptional regulation MeCP2 provides is unclear as 
MeCP2 has been found to both repress transcription better than histone H126 and 
activate transcription71. Using in vitro methods to probe individual properties of MeCP2’s 
relationship to nucleosomes and chromatin we have shown some features that could 
provide insight into these apparent antagonistic roles of MeCP2. Our results both 
confirm that unmodified MeCP2 acts as a repressive CAP on epigenetically neutral 
nucleosomes and gives insight into how MeCP2 can also switch into an activating CAP. 
The mononucleosome FRET studies show that, like the repressive CAP histone H1, 
MeCP2 stabilizes compacted nucleosome conformations (figs 5.3 and 5.7) and hinders 
Gal4 1-147 from binding its target site (fig 5.12). However, MeCP2 had a lower affinity 
for chromatosome formation (figs 5.1 and 5.5) and was unable to compact nucleosomes 
as tightly as histone H1 (fig 5.5). Furthermore, our 17-mer studies show that both 
activating and repressive CAPs stabilized higher order structures (figs 4.1, 4.3, and 4.4) 
and limit DNA accessibility (fig 4.2). Thus, our work has provided the groundwork 
needed to study MeCP2 mediated regulation in a variety of epigenetic environments, 
which is necessary given the many different binding partners and modifications with 
which MeCP2 is associated. 
 MeCP2 has a higher affinity for methylated DNA, both in linear184 and 
nucleosomal65 orientations. However, we do not know if this difference in affinity will 
change the compactness of MeCP2 chromatosomes. Our FRET system can be used to 
provide a direct comparison of MeCP2 affinity to form methylated and non-methylated 
chromatosomes and simultaneously determine if this difference in affinity also changes 
MeCP2’s effect on nucleosome breathing and compaction. Furthermore, when MeCP2 is 
nonfunctional, there is an increase in the transcriptional noise, especially in long non-
tandem repeats26 and long genes60. This is not due to a lack of CAP mediated regulation 
in these areas as histone H1 levels double in neurons and take over the regulation of 
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these genomic areas26. Therefore, MeCP2 provides better repression of these long 
transcript than histone H1. Interestingly, even though the nucleosomes in our work were 
not methylated, MeCP2 is able to limit Gal4 binding to the same extent as histone H1 (fig 
5.12). It will be very interesting to see if the predicted higher affinity for methylated 
chromatosome formation is accompanied by a change in chromatosome conformation 
and a change in DNA target site accessibility. While it is clear that the level of 
compaction stabilized by MeCP2 in unmodified chromatosomes is adequate for 
repression, tighter compaction could further indicate how MeCP2 leads to more 
repression.  
While our studies provide experimental support for the repressive nature of 
unmodified MeCP2, there are also results that could potentially explain why MeCP2 is 
able to switch from a very tight repressor to an activator. In the higher order studies, we 
were unable to detect differences in the structural support (figs 4.1, 4.3, and 4.4) and 
DNA accessibility (fig 4.2) provided by activating and repressive CAPs. Our FRET 
studies, however, showed difference in the mononucleosome conformation provided by 
each CAP (fig 5.5). MeCP2 stabilizes a nucleosome conformation that produces terminal 
FRET efficiency almost exactly halfway between the terminal FRET efficiencies of the 
model activating and model repressive CAPs (fig 5.5). While this difference in 
compaction does not change MeCP2’s ability to limit Gal4 1-147’s binding (fig 5.12), it 
could be key in switching from repression to activation. It will be interesting to see if 
MeCP2’s activating capabilities can be recreated in vitro since reports suggest the 
MeCP2 works with co-activating complexes (e.g. CREB)71 to activate transcription, while 
other reports show MeCP2-mediated transcriptional activation is associated with 
hydroxymethylated DNA without mention of co-activating complexes200,209. Accordingly, 
future studies of MeCP2 should not be limited to nucleosomes with methylated DNA, but 
should also include specific histone PTMs, DNA hydroxymethylation, and various 
combinations of these epigenetic signatures in order to understand the important 
nuances of MeCP2’s binding and regulatory capabilities. 
 One of the most exciting aspects of our FRET system is its potential for studying 
RTT causing MeCP2 mutations. The FRET system allows us to decouple nucleosome 
binding and changes in DNA accessibility. Since most loss of function mutations of 
MeCP2 affect its ability to bind nucleosomes (mutations in the methyl binding domain 
[MBD])46,48,210-212 and/or regulate transcription (mutations in the transcriptional repression 
domain [TRD])42,48,148,210,213, being able to look into these two distinct functions of MeCP2 
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will be critical in order to understand what MeCP2 mediated functions are disrupted in 
RTT. For example, R106W and T158M mutations occur in the MBD. While both affect 
MeCP2’s affinity for methylated DNA, they do so to different extents25,64. Furthermore, it 
is unknown if these mutants retain their repressive capabilities if this difference in affinity 
for chromatosome formation is compensated for209. The R306C mutation occurs in the 
TRD and therefore does not affect MeCP2’s affinity for chromatosome formation25,48,131. 
However, the mutation’s effect on MeCP2-regulated DNA accessibility is unknown. It will 
also be interesting to see how point mutations in the TRD compare to truncation 
mutations which, in addition to altering the TRD, should also affect the cooperative 
binding of MeCP2 to chromatin24. Moreover, there are mutations that should, 
theoretically, behave identically with nucleosomes as MeCP2 as they either have a 
mutation that affects their ability to interact with other co-regulatory complexes27,28,53, or 
are at sites that are post translationally modified72,214-216, yet this is not been confirmed 
experimentally. 
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